Assessment of Vitamin D Levels and Depression Among Adults in the United States by Owens, Troy Jean-Luc
Walden University
ScholarWorks
Walden Dissertations and Doctoral Studies Walden Dissertations and Doctoral StudiesCollection
2015
Assessment of Vitamin D Levels and Depression
Among Adults in the United States
Troy Jean-Luc Owens
Walden University
Follow this and additional works at: https://scholarworks.waldenu.edu/dissertations
Part of the Epidemiology Commons, and the Public Health Education and Promotion Commons
This Dissertation is brought to you for free and open access by the Walden Dissertations and Doctoral Studies Collection at ScholarWorks. It has been
accepted for inclusion in Walden Dissertations and Doctoral Studies by an authorized administrator of ScholarWorks. For more information, please
contact ScholarWorks@waldenu.edu.
 
 
 
 
 
 
 
Walden University 
 
 
 
College of Health Sciences 
 
 
 
 
This is to certify that the doctoral dissertation by 
 
 
Troy Jean-Luc Owens 
 
 
has been found to be complete and satisfactory in all respects,  
and that any and all revisions required by  
the review committee have been made. 
 
 
Review Committee 
Dr. John Nemecek, Committee Chairperson, Public Health Faculty 
Dr. Raymond Panas, Committee Member, Public Health Faculty 
Dr. Mehdi Agha, University Reviewer, Public Health Faculty 
 
 
 
 
 
Chief Academic Officer 
Eric Riedel, Ph.D. 
 
 
 
Walden University 
2015 
 
 
 
 
 
 
Abstract 
Assessment of Vitamin D Levels and Depression Among Adults in the United States 
by 
Troy Jean-Luc Owens 
 
MPH, Walden University, 2011 
BS, University of California, San Diego, 2000 
 
 
Dissertation Submitted in Partial Fulfillment 
of the Requirements for the Degree of 
Doctor of Philosophy 
Public Health 
 
 
Walden University 
March 2015 
 
 
 
 
 
 
 
 
 
 
Abstract 
Vitamin D is essential to optimizing health; vitamin D deficiency (VDD) can increase 
risk of hypertension, cardiovascular disease, and insulin resistance.  VDD occurs when 
individuals do not receive sufficient oral intake or obtain adequate sun exposure. 
Previous researchers indicated there is a relationship between VDD and depression, while 
others have indicated there is no relationship.  The purpose of this study was to examine 
the relationship between vitamin D levels and depression, and how this relationship 
might be moderated by an individual’s demographic characteristics (gender, age, 
smoking status, or marital status).  This study was a quantitative data analysis of archival 
data from the 2005-2006 National Health and Nutrition Examination Survey.  The Health 
Belief Model was the theoretical framework. An ex-post facto exploratory analysis was 
used to test 2,623 adults located throughout the United States.  Employing moderated 
multiple regression, a significant relationship was found between vitamin D levels and 
depression (p. < .001); however, the relationship was not moderated by demographic 
characteristics (gender, age, smoking status, or marital status).  This study supports prior 
researchers who affirmed a correlation between vitamin D levels and depression. Given 
the definitive findings, practitioners should continue to recommend intake of vitamin D 
to individuals not meeting recommended daily dosages, but recommendations should not 
be based on gender, age, smoking status, or marital status. Understanding the connection 
between VDD and depression provides a basis on which to foster positive social change 
at the individual, family, organizational, and societal level.  
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Chapter 1:  Introduction to the Study 
Background of the Study 
Vitamin D deficiency (VDD) can affect individuals of any age, race, or gender 
(Lappe, 2011).  Vitamin D receptors exist in almost all human tissue and cells, and 
sufficient levels are important for optimum operation of those tissues and cells (Lappe, 
2011).  VDD can lead to multiple health consequences, including a major mood disorder 
(e.g., depressed mood, abated interest, altered appetite, sleep disorder, exhaustion, 
psychomotor disorder, feelings of inadequacy, inability to make decisions, and suicidal 
speculation; Wilkins, Sheline, Roe, Birge, & Morris, 2006).   
At-risk groups for VDD include the elderly, women, and those with a history of 
chronic illness (e.g., diabetes, heart attack, stroke, and/or cancer; Hoang et al., 2011).  
These same at risk groups are also at risk for depression (Dong, Zhang, Tong, & Qin, 
2012; Gross, Gallo, & Eaton, 2010; Pan et al., 2011). Despite considerable research 
linking VDD with depression, the evidence remains controversial, because some 
researchers have concluded that there is no relationship between VDD and depression 
(Bertone-Johnson, 2009; Harris & Dawson-Hughes, 1993; Kwasky, & Groh, 2012; 
Schneider, Weber, Frensch, Stein, & Fritze, 2000).  Results have been inconsistent and 
inconclusive (Bertone-Johnson, 2009).   Additional investigation is warranted to better 
understand whether there is a relationship between these two conditions.   
According Bertone-Johnson (2009), confounding variables often interfere in 
research focusing on vitamin D and depression due to multiple factors (e.g., aging, period 
of time living indoors, geographic coordinates, physical exercise, weight, and drug use) 
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that can alter 25(OH)D (a prehormone that is formed in the liver through hydroxylation 
of vitamin D3; cholecalciferol) levels, many of which cannot be controlled.  Further, the 
epidemiological evidence on whether hypovitaminosis D (i.e., deficiency of vitamin D) is 
associated with depression remains limited (McCann & Ames, 2008; Milaneschi et al., 
2013).  More investigations are needed to determine if preventive or treatment 
interventions for depression should be coupled with preventing hypovitaminosis D as a 
cost-effective form of treatment (Holick, 2004; Milaneschi et al., 2013).  
Such investigation is necessary because both VDD and depression are two major 
public health concerns that have significant implications for those who suffer from either 
condition.  Whether the two health conditions are associated with each other requires 
further research.  Addressing VDD and depression via cost-effective, safe, and effective 
public health measures may be an appropriate means to lowering the rates of both adverse 
health conditions.  This study was designed to contribute to the existing base of 
scholarship in this area.  This chapter includes an introduction to the study, including the 
problem and purpose of the research, the guiding research questions, and the nature of the 
study.  The theoretical framework is also presented, along with relevant definitions that 
will be used throughout the study.   
Problem Statement 
The direction and result of common chronic conditions (e.g., arthritis, asthma, 
cardiovascular disease, cancer, diabetes, and obesity) could be adversely impacted by 
depression (Centers for Disease Control and Prevention [CDC], 2012a).  If depression is 
left untreated, job absence, low job performance, and diminished work productivity can 
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result (CDC, 2012a).  Similarly, vitamin D levels are often examined during routine 
physical exams and VDD is linked to risk for multiple health issues (Grineva, Karonova, 
Micheeva, Belyaeva, & Nikitina, 2013).  For instance, vitamin D deficiency is a relevant 
and significant risk factor implicated in many health conditions such as cardiovascular 
disease, type 2 diabetes, obesity, rickets, osteomalacia, and progressive renal function 
loss (de Borst et al., 2011; Grineva et al., 2013).  
 Given the significant health risks that are associated with VDD and depression, it 
is important to fully understand the potential correlation between the two.  However, the 
association between VDD with depression remains limited (McCann & Ames, 2008; 
Milaneschi et al., 2013).  There is a possibility that the inconsistencies in the prior 
research stem from a failure to identify any possible differences in this relationship by 
gender, age, smoking status, or marital status.  Without such understanding, prevention 
and intervention strategies designed to address both conditions will be limited. The 
research problem addressed in this study is whether or not vitamin D levels effect 
depression, and if covariates (gender, age, smoking status, or marital status) have an 
impact. 
Purpose 
I examined the relationship between vitamin D levels and depression, and how 
this relationship might be moderated by an individual’s demographic characteristics 
(gender, age, smoking status, or marital status).  There is evidence that vitamin D is 
essential to optimizing health and preventing disease (Bertone-Johnson, 2009).  There is a 
need to determine if VDD is physiologically related to the occurrence of depression 
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(Bertone-Johnson, 2009).  The intent of this study was to explore whether there is a 
relationship between vitamin D levels and depression, and how this might be moderated 
by an individual’s demographic characteristics such as gender, age, smoking status, or 
marital status. 
Research Question 
To guide this quantitative study, one research question was used.  The variables of 
interest included vitamin D, depression, and demographic characteristics.  The research 
question was: 
Research Question 1:  What is the relationship between vitamin D levels and 
depression and is it moderated by demographic characteristics (gender, age, smoking 
status, or marital status)? 
H0:  There is no relationship between vitamin D levels and depression and it is not 
moderated by demographic characteristics (gender, age, smoking status, or marital 
status). 
HA:  There is a relationship between vitamin D levels and depression and it is 
moderated by demographic characteristics (gender, age, smoking status, or marital 
status). 
Nature of the Study 
 To answer the stated research question, a quantitative, ex post facto 
comparative research design was used.  Data were extracted from the National Health and 
Nutrition Examination Survey (NHANES), which was administered in 2005-2006 (CDC, 
2013).  NHANES is a well-established program in the United States designed to monitor 
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a variety of health and nutrition measurements and status of adults and children (CDC, 
2013).  The study’s sample consisted of adults who were at least 18 years old located in 
the U.S.  To be included in the sample, adults must have taken part of the NHANES in 
2005 – 2006.  Approximately 4,773 individuals, aged 18 years and older, participated in 
the study (CDC, 2013b).   
For the single research question, a moderated multiple regression (MMR) analysis 
was incorporated.  Depression was the single criterion variable, while vitamin D levels 
were the predictor variable.  A moderator was introduced to attempt altering the 
relationship between other variables.  This can help gauge whether a relationship between 
the predictor variable and moderation variables occurs on the criterion variable (Keith, 
2006).  The moderation variables for the hypothesis are gender, age, smoking status, and 
marital status.  As such, MMR determined if specific demographic characteristics have an 
impact on the relationship between depression and vitamin D levels.  MMR allowed me 
to determine if a predictor variable is correlated to the criterion variable, followed by 
estimating the magnitude of any effect. MMR enabled me to determine the unknown 
value of a variable from the known value of two or more variables.  However, the size of 
the sample was to be relatively large to determine statistical power.  A relatively small 
sample could lead to failure of detecting a moderating effect (Aguinis 2004). 
Assumptions 
A number of assumptions were critical to the meaningfulness of this study and 
were implicit to the design of this study.  I assumed that testing the relationship between 
VDD and depression among sociodemographic subgroups was necessary to the context 
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of this study, and could be discernible when using a large sample size.  The health belief 
model (HBM), which provided the theoretical framework for this study, was assumed to 
be necessary because this model can explain behaviors.   
There is an assumption that all research protocols, statistical processes and ethical 
protections outlined by the NHANES were followed, and that all participants in the 
NHANES survey answered fully, honestly, and to the best of their ability.  Accurate 
instrumentation and feedback supported the validity of the national surveillance survey.  
It was assumed that the sampling methodology of collecting relevant data from NHANES 
documents was meaningful in order to analyze the material and address the research 
question and hypotheses. 
Scope and Delimitations 
The conceptual framework for this study applied the HBM deductively as a 
logical process in order to focus on the attitudes and beliefs of participants.  The research 
question and hypothesis was verified by the HBM.  NHANES datasets were examined 
according to adults ≥ 18 years with VDD and depression who volunteered information 
pertaining to the predictor variable and the criterion variables during a specific period 
(2005-2006).   
This study was delimited to adults who are at least 18 years old, located in the 
United States, and who have taken part within a specified biannual (2005-2006) 
NHANES dataset(s).  The extent of the research study focused solely on the hypotheses 
and did not surpass the theoretical foundation that the research study was established 
upon.  Depression and VDD were measured using an instrument designed to monitor a 
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variety of health and nutrition measurements.  The study’s results were generalizable 
only to adults who take part in the NHANES.  
Limitations 
There were multiple limitations to the design of this study.  The hydrophobic 
qualities of vitamin D and the tight binding that occurs to the vitamin D binding protein 
can inhibit accurate measurements (Romagnoli, Pepe, Piemonte, Cipriani, & Minisola, 
2013).  The pseudo-quantitative nature of the method (i.e., subjective data that are 
assigned numeric values without objective affirmation) served as a form of misreporting, 
which can constitute as a limitation.  Concerning quality control purposes, only 5% of the 
interviews were recorded and reviewed (CDC, 2013).  Not all interviews are reviewed, 
which may indicate a misrepresentation to the general audience. 
While it may appear suitable to implement the conclusion to the population, it 
may not be a correct or proper assumption to all volunteers who resided in various areas 
of the U.S.  Persons who were U.S. nationals living abroad, institutionalized, or residing 
in nursing homes, were excluded from this study and were not examined. The concern of 
generalization was described as a limitation to this present study.  Criteria for 
participating required that volunteers who were at least 18 years old, located in the 
United States, were not institutionalized, and who were mentally able to respond to a 
questionnaire.  These requirements reduced the ability to generalize results to the U.S. 
population as a whole.  Lastly, Statistical Package for the Social Sciences (SPSS) was 
used to appropriately examine data; however, limitations existed due to examiners being 
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required to appropriately interpret information that may have required additional 
learning. 
Theoretical Framework 
The HBM, developed during the 1950s by psychologists Rosenstock, Hochbaum, 
and Kegels, is a psychological health behavior change model that is grounded in the 
sociopsychological theory of thought processes to health-related behaviors of an 
individual (Harrison, Mullen, & Green, 1992).  It is hypothesized that for an action to be 
health-related, the individual must be dependent on three factors that occur 
simultaneously: (a) a health concern must exist for an issue to be considered relevant, (b) 
one must believe that they are vulnerable to a perceived health threat or condition, and (c) 
a belief that abiding by suggested health recommendation could be helpful to avoiding or 
lowering the possible threat at a cost (i.e., financial) that is relatively acceptable (Edberg, 
2010; Janz & Becker, 1984; Rosenstock, 2005). 
People often fail to take health-related action or comply with medical advice 
because they do not recognize the benefits of protecting their health (Rosenstock, 2005).  
Individuals who fail to take corrective action often believe they will not be impacted by 
an illness.  They fail to believe that personal intervention can avoid or stabilize a 
condition that they are faced with (Edberg, 2010; Janz, & Becker, 1984; Rosenstock, 
2005).  HBM is a model that addresses behavioral change (Rosenstock, 2005). 
The HBM is relevant to addressing VDD and depression because the conceptual 
framework provided by the HBM is effective in understanding health behavior and 
possible reasons for non-compliance (i.e., not engaging in behaviors to avoid VDD and 
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depression).  The HBM consists of six concepts: (a) perceived susceptibility, (b) 
perceived severity, (c) perceived benefits, (d) perceived barriers, (e) cues to action, and 
(f) self-efficacy that represent perceived threat and net benefits (Akompab et al., 2013).  
These concepts facilitate health action and can be applied to address reasons an 
individual may be non-compliant (Rosenstock, 2005).   
According to Carpenter (2010), the HBM was developed so that researchers could 
understand the beliefs that should be targeted to influence health behaviors.  However, 
the HBM was not designed to determine if subjects would adhere to a treatment program 
for an existing condition.  Rather, the HBM was developed so that researchers may 
understand the benefits and barriers to predicting behaviors directed toward preventing 
negative health outcomes (Janz & Becker, 1984).  HBM was not designed to predict 
treatment for existing disorders, but was rather initiated to predict the compliance of 
preventative measures with those who are not suffering from an existing disabling disease 
(Rosenstock, 1974).   
According to Janz and Becker (1984), a cue to action is necessary to generate 
health-promoting behavior. The HBM theory related to this study’s approach and 
research question by examining predictors of depression in persons with VDD.  This 
study will enhance the general public’s understanding to predictors of depression in 
persons with VDD.  This study will contribute to existing research involving any 
association between depression and VDD, which may help address an area that is in need 
of further research. 
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Significance 
This study will have significance for both scholarship and practice in public 
health education.  Understanding if a relationship between VDD and depression is 
impacted by demographics (gender, age, smoking status, and marital status) is important 
for preventive strategies when allocating resources and targeting education programs.  
This study can also assist in further research of distinguishing those groups at risk for 
VDD and depression as an implication for positive social change, which is consistent 
with and bounded by the scope of this study.  Such potential contributions may advance 
practice by targeting solutions toward these stakeholders.  
The correlation among vitamin D status, cognition, and mood has been 
documented in previous studies (McCann & Ames, 2008; Wilkins et al., 2006), where 
some conclude that treating VDD improves depression symptoms (Benton, Haller, & 
Fordy, 1995; Mozaffari-Khosravi, Nabizade, Yassini-Ardakani, Hadinedoushan, & 
Barzegar, 2013). VDD may be indicative to underlying biological vulnerability for 
depression, but further research is warranted (Milaneschi et al., 2013). According to 
Nemeroff and Vale (2005), there is a strong possibility that psychiatric illnesses result in 
increased vulnerability when coupled with environmental influences.  In addition, some 
studies have found VDD to be associated with multiple chronic debilitating diseases (e.g., 
osteoarthritis, cardiovascular disease, and type 1 diabetes; Holick, 2004; Tamai et al., 
2013).   
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Definitions 
Age: Age is interpreted as the amount of time during which a person has lived 
(Merriam Webster, 2013a). 
Depression: Depression is a serious medical condition in which a person feels 
very sad, hopeless, and unimportant and often is unable to live in a normal way (Merriam 
Webster, 2013a).  Depression is defined as a person acknowledging of having thoughts of 
hurting oneself in some way or considering oneself as being better off dead, despite the 
timeframe (CDC, 2013b). 
Income: Income is defined as a gain in money that derives from capital received 
in a period of time (Merriam-Webster, 2013b). 
Marital status: Marital status is defined as married, widowed, divorced, separated, 
never married, and living with partner (CDC, 2013). 
Sex: Sex is defined as the state of being male or female (Merriam Webster, 
2013c). 
Smoking: Smoking is defined as the act of smoking a cigarette, cigar, etc. 
(Merriam Webster, 2013d). 
Socioeconomic status: Socioeconomic status is defined as a composite measure 
that typically incorporates economic, social, and work status (CDC, 2013). 
Vitamin D: Vitamin D is defined as any or all of several fat-soluble vitamins 
chemically related to steroids, essential for normal bone and tooth structure, and found 
especially in fish-liver oils, egg yolk, and milk or produced by activation (as by 
ultraviolet irradiation) of sterols as calciferol orcholecalciferol (Merriam-Webster, 
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2013b). 
Vitamin D deficiency (VDD): Vitamin D deficiency is defined as a serum 25-
hydroxyvitamin D concentrations ≤20 ng/mL (50 nmol/L; Forrest & Stuhldreher, 2011). 
Summary 
 Some researchers have indicated that there is an association between depression 
and vitamin D (Wilkins et al., 2006), while some researchers concluded that the data 
associating vitamin D to the development of depression is circumstantial due to 
inconsistencies in research findings (Bertone-Johnson, 2009; Harris & Dawson-Hughes, 
1993; Kwasky, & Groh, 2012; Schneider et al., 2000).  Determining whether a 
relationship exists between vitamin D levels and depression, and if it is moderated by 
demographic characteristics (gender, age, smoking status, or marital status) may help 
public health practitioners uncover preventive strategies and allocate resources that target 
education programs.  Findings in this study, which focused on the general U.S. 
population, may contribute to the goal of Healthy People 2020 by gradually eliminating 
demographic disparities and improve mental health through prevention. 
Previous researchers have studied vitamin D status, cognition, and mood 
(McCann & Ames, 2008; Wilkins et al., 2006). The use of NHANES enabled provisional 
diagnoses for depression and assisted with grading the severity of depressive symptoms 
(CDC, 2013b).  However, what remained unknown is if variables served as important 
indicators for VDD and depression when coupled with gender, age, smoking status, or 
marital status.  What was needed is an empirical understanding of how risk for VDD and 
depression function due to gender, age, smoking status, or marital status.  
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 I intended to examine a representative sample of the U.S. population.  Public data 
between 2005 and 2006 was obtained from the NHANES.  The literature review 
described in Chapter 2 is an overview of the relationship between VDD and depression.  
A more detailed explanation of the HBM is provided in Chapter 2.  Chapter 3 is the 
design and methodology.  Chapter 4 is the results and analyses.  Finally, Chapter 5 is an 
interpretation of these findings and concludes with a description of recommendations. 
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Chapter 2:  Literature Review 
Introduction 
 I evaluated the association between vitamin D and depression.  There is a paucity 
of epidemiological research data regarding the association VDD with depression 
(Milaneschi et al., 2013).  A better interpretation of the association between depression 
and vitamin D levels could possibly lead to greater self-efficacy. Kennel, Drake, and 
Hurley (2010) argued that VDD occurs when individuals do not receive sufficient oral 
intake or obtain adequate sun exposure. Demographic factors such as gender, age, and 
smoking status may contribute to individuals becoming deficient (Lange, Sparrow, 
Vokonas, & Litonjua, 2012; Nanri et al., 2011).  
Given adequate support, individuals at risk for VDD can more easily address 
behaviors related to diet, lifestyle, screening, and convenient access to treatment (CDC, 
2011).  Bridging potential gaps in the literature may help support public health initiatives 
involving promotional efforts geared toward increasing awareness and providing 
reminders of health-related action (i.e., receiving adequate amounts of vitamin D).  
Achieving a greater understanding of demographic factors and their association between 
depression and vitamin D levels could possibly enhance public health education 
strategies involving a person’s motivation to take positive health actions against VDD 
(CDC, 2011).  
This review of the literature begins with an exploration of HBM, which provides 
the theoretical framework for this study.  The limited body of available literature that has 
examined the connection between VDD and depression is synthesized in this chapter.  I 
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provide background information on depression and on vitamin D and its biochemical 
mechanisms.  The chapter concludes with an exploration of public health education 
efforts that have focused on both depression awareness and mental health as well as the 
promotion of vitamin D. 
Literature Search Strategy 
The primary objective of the literature search was to review the key concepts of 
depression and vitamin D.  The secondary objective was to explore scholarly reviews 
pertaining to depression and vitamin D to address the stated research question of this 
study. The literature search consisted of scholarly peer reviewed literature to avoid 
circulating insignificant findings, baseless claims, unsuitable analyses, and bias.  
Literature for this study was gathered from scholarly journal articles, books, Walden 
University research databases, University of California San Diego research databases, 
Centers for Disease Control and Prevention databases, United States National Library of 
Medicine, National Institutes of Health, and Google Scholar dating from 1930 to May 
2014, searching varying methodologies to review the progression, distribution, and risk 
factors of depression and vitamin D.  Peer-reviewed articles contained in this study were 
reviewed to obtain influential data and information pertaining to the scope of my study. 
Secondary searches for scholarly, peer-reviewed journal articles available in print-only 
format were obtained from the University of California San Diego Library.   The 
literature search encompassed the key words depression, calcitriol, gender, age, smoking 
status, marital status, NHANES, treatment, recurrence, brain function, health risks, and 
education. 
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Theoretical Framework 
        The theoretical framework for this study is the HBM.  The HBM was developed 
during the 1950’s by social psychologists Rosenstock, Hochbaum, and Kegeles (1974).  
This model is validated to function as a guiding theoretical framework in the scope of 
preventive health behavior and compliance (Rosenstock, 2005).  The HBM is used to 
understand health behaviors and possible predictors of depression in persons with VDD.  
The central tenet of the HBM is that an individual will partake in health-related action in 
order to avoid an adverse outcome (Trifiletti, Gielen, Sleet, & Hopkins, 2005).  In 
addition, the HBM postulates that if an individual is in favor of avoiding a negative 
outcome, he or she will take a recommended health action.  Conversely, the HBM 
indicates that unhealthy behaviors can result if an individual perceives they are not at risk 
for a potentially negative outcome (Institute of Medicine, 2001).  For example, an 
individual who may be at risk for depression and wishes to avoid that situation is more 
likely to take preventive recommendations such as seeking treatment than an individual 
who is unconcerned about their potential risk for depression.   
The interaction between perceived risk and health behavior advanced by the HBM 
suggests that awareness and education about health issues can positively affect change 
through improvements in individual health behavior.  The HBM relates to the present 
study and research question by examining predictors of depression in persons with VDD.  
The material collected in this study may have a significant impact on social change by 
providing efficient measures (e.g., screening and counseling) for patients with VDD to 
successfully respond to depression. 
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Association between Depression and Vitamin D Deficiency 
        Vitamin D receptors (VDR) and hydroxylases (i.e., enzymes that facilitate 
hydroxylation) in different areas of the brain confirm the existence of vitamin D in its 
bioactive form, known as calcitriol (Eyles, Smith, Kinobe, Hewison, & McGrath, 2005; 
Prüfer, Veenstra, Jirikowski, & Kumaret, 1999).  VDR and hydroxylases are located 
central to the limbic system, which is where emotional and behavioral regulation occur 
(Walbert, Jirikowski, & Prüfer, 2001).  Depressive symptoms and impaired cognition are 
associated with VDR gene polymorphisms (Kuningas et al., 2009).   
Beyond VDR gene polymorphisms, depressive symptoms are associated with 
vitamin D status, and the neurobiological plausibility of this association is strengthened 
by data that indicates VDD influences inflammation (Capuron et al., 2003; McCann & 
Ames, 2008). Although inflammation may contribute to depression (Miller, Maletic, & 
Raison, 2009), vitamin D’s immunomodulatory activity may partake by down-regulating 
inflammatory mediators (e.g., nuclear factor κB) that are connected to depression 
(Capuron et al., 2003; McCann & Ames, 2008). According to Miller et al. (2009), active 
inflammatory pathways in the brain are similar to neuropathologic findings (i.e., a 
junction of reduced neurotrophic aid and modified glutamate release and reuptake) that 
represent depressive disorders. 
Consequences of Vitamin D Deficiency 
People who feel depressed (i.e., sad or anxious) each year during the same season 
are often considered to have seasonal affective disorder (SAD) that is consequential to 
VDD (Gloth, Alam & Hollis, 1999).  Gloth et al. (1999) studied 15 participants with 
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SAD in a prospective and randomized trial to measure the hypothesis that VDD is 
associated with SAD.  According to Gloth et al., phototherapy was administered to seven 
participants and 1,000,000 international units (IU) of vitamin D were administered to 
eight participants.  Gloth et al. discovered that there was an association in the progress 
between depression scale scores and concentrations of circulating vitamin D (p=0.05; 
r2=0.26) based on all subjects who received vitamin D improved in all outcome 
measures. Although no significant changes were found in depression scale measures with 
those receiving phototherapy, significant changes were found with those receiving serum 
vitamin D. 
Variables Impacting the Relationship between Depression and Vitamin D Deficiency   
 Age.  A cross-sectional study involving 3,262 Chinese participants who were 
aged 50-70 years were measured according to depressive symptoms and concentrations 
of circulating 25(OH)D (Pan et al., 2009).  Symptoms of depression were determined by 
a Center for Epidemiologic Studies Depression Scale (CESDS) score (Pan et al., 2009).  
Radioimmunoassay’s were measured to determine circulating 25(OH)D concentrations 
(Pan et al., 2009).  However, causal relations remained unknown.  In addition, 
investigators concluded that symptoms of depression in adult Chinese had no association 
correlated with 25(OH)D concentrations (Pan et al., 2009). 
Sex.  A population-based cohort study involving 423 men and 531 women over 
the age of 64 years was performed to uncover the association between 25(OH)D and 
symptoms of depression (Milaneschi et al., 2010).  Assessments of depressive symptoms 
using the CESDS were taken at baseline, 3-yr, and 6-yr follow-up.  The CESDS consists 
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of a scale that is self-reported and has 20 items, which ranges from 0 to 60 points.  A 
score higher than 15 is typically considered to signify clinically relevant symptoms of 
depression. 
Women with 25(OH)D greater than 50 nmol/L distinguished from women having 
levels less than 50 nmol/L, had experienced CESDS results of 2.2 (P=0.04) and 2.1 
(P=0.02) points, respectively (Milaneschi et al., 2010).  The prevalence of depressed 
mood was 18% for males and 42% for females. Nearly 75% of females and 50.4% of 
males had serum 25(OH)D less than 50 nmol/liter (P < 0.0001), which suggests that the 
weight of the prospective relationship is greater among females compared with males 
(Milaneschi et al., 2010).  Milaneschi et al. (2010) concluded that there is a stronger 
prospective association among women than men regarding VDD as a risk factor for 
development of depressed mood (i.e., depressed mood was determined by CESDS score 
of  > 15). 
Smoking.  A double blind and randomized study investigated by Jorde, Sneve, 
Figenschau, Svartberg, and Waterloo (2008) examined 441 participants (159 men and 
282 women) to investigate the relationship between serum 25(OH)D levels and 
depression. Jorde et al. determined that smokers compared with nonsmokers were more 
depressed.  Participants measured their main outcome using the Beck Depression 
Inventory (BDI) score; smokers scored non-significantly higher as having clinically 
relevant symptoms of depression when compared to nonsmokers (Jorde et al., 2008).  
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Income.  Ganji, Milone, Cody, McCarty, and Wang (2010) examined the 
relationship between vitamin D status and depression of the US general population at 
large. Those who were VDD (25(OH)D≤75 nmol/L) had a prevalence of approximately 
50% (Ganji et al., 2010).  The sample population consisted of 7970 participants, women 
comprised approximately 54% of this group, while 67% were African American and 
Mexican American (Ganji et al., 2010). Further, approximately, 27% lived below 
poverty, and approximately 4% noted that depression occurred during periods of taking 
the examination (Ganji et al., 2010).  Participants living below poverty levels reported a 
higher prevalence of VDD compared with participants living above poverty levels (Ganji 
et al., 2010). 
Vitamin D Deficiency.  VDD is reported in areas with sufficient resources as 
often as it is reported in areas with limited resources, which places children and adults at 
risk of complications (e.g., rickets osteomalacia, and osteoporosis) (Handa, Ali Kalla, & 
Maalouf, 2008; Prentice, 2008; Robinson et al., 2006) regardless of place of origin 
(Prentice, 2008).  In areas where resources are limited, contributors to VDD are often 
linked to insufficient dietary intake of vitamin D (Awumey, Mitra, Hollis, Kumar, & 
Bell, 1998).  However, most vitamin D originates from determinants not contained in 
one’s diet, rather from non-dietary sources (e.g., inadequate sun exposure, skin 
pigmentation, clothing, keeping infants indoors; Holick & Chen, 2008; Munns et al., 
2006). The biochemical characteristics of vitamin D show strong potential in minimizing 
risk of depression and mitigating depressive symptoms.   
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In order to realize the benefits of this correlation, it is essential to recognize the 
biochemical factors that underlie depression, as well as the biochemical characteristics 
involved with vitamin D.  It is also important to understand the health behavior 
considerations associated with vitamin D, including discernment that over 40% of 
Americans are vitamin D deficient (Forrest & Stuhldreher, 2011).  Thus, it is critical that 
more Americans be educated about the benefits of vitamin D to mental health, and aware 
about how to achieve sufficient vitamin D levels.     
Depression 
Depression is a condition that reaches beyond feelings of sadness or 
consternation.  Each year in the U.S., depression affects approximately 14.8 million 
adults, or 6.7% of those 18 years and older (Kessler, Chiu, Demier, & Walters, 2010). 
Globally, approximately 350 million people are subject to depression (World Health 
Organization, 2013). According to Kessler et al. (2010), depression can affect 
approximately one in six men and one in four women in their lifetimes.  Depression can 
negatively impact a person’s quality of life, such as increasing one’s risk of mortality 
(Katz et al., 2010). 
The American Psychiatric Association (2012b) described depression as a serious 
medical illness that adversely affects ones feelings, thoughts, and actions.  The onset of 
depression can result into a range of symptoms (e.g., feelings of sadness, loss of 
enjoyment in activities that were previously enjoyable, insomnia, and difficulty thinking).  
Depression is often caused by biochemical abnormalities (i.e., an imbalance in serotonin 
and norepinephrine levels may regulate mood that may lead to depression), genetics, 
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personality traits, and environmental factors (vitamin deficiency, exposure to violence, 
abuse, or poverty) that can affect anyone (American Psychiatric Association, 2012b). 
Depression affects men and women differently, and risk of depression varies over 
the course of an individual’s lifetime. Gender has a direct correlation to depression, with 
females more likely to experience depression than males.  Females are often twice as 
likely to encounter major depressive disorder  (MDD) as males (Kessler, McGonagle, 
Swartz, Blazer, & Nelson, 1993; Weissman & Klerman, 1977; Weissman et al., 1993).  
This appearance of gender variation in depression may be regarded as biological factors 
(e.g., genetics, neurotransmitters, and hormones) and victimization (e.g., childhood 
trauma, restrictive gender roles; Ryba & Hopko, 2011). 
The average age of onset for depression is 32 years (National Institute of Mental 
Health, 2013).  However, persons 18 to 25 years are more likely to report suicidal 
thoughts and episodes of MDD (Substance Abuse and Mental Health Services 
Administration, 2013).  Further, the highest rates for depression occur from ages 49 – 54 
years (University of Maryland Medical Center, 2013).   
        Mental health disorders, such as major depressive disorder, are treatable through 
the use of psychotherapy and anti-depressant medications (American Psychiatric 
Association, 2012b). According to the National Institute of Health (2008), 13.4% of 
adults in 2008 received treatment for a mental health disorder.  That same year, 71% of 
adults with major depression, mostly women over 50 years, were found to use mental 
health services and treatment (National Institute of Health, 2008). 
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Signs and Symptoms of Depression 
Depression is a medical condition, which if left untreated, can interfere with 
person’s daily activities and prevent them from conducting normal activities (CDC, 
2011).  Symptoms can include persistent sadness, anxiousness, or a feeling of emptiness, 
which can adversely impact daily activities by contributing to disturbances in sleep, 
reverting to physical inactivity, and increased risk for smoking (CDC, 2011).  Symptoms 
of depression involve the combination of these symptoms, adversely interfering with 
daily activities; these symptoms may range in severity, frequency, and duration (National 
Institutes of Mental Health, 2104; New York State Office of Mental Health, 2012). 
Causes of Depression 
According to the National Institutes of Health (2014), depression can occur based 
on a variety of factors (e.g., genetic, biological, environmental, or psychological).  
However, there is a paucity of research involving neurobiological basis and 
pathophysiology related to depressive disorders. Correlations have been identified 
between genetics and depression, as indicated with researchers investigating adoptions 
and twins (Lohoff, 2010).  Despite vast improvements genome-associated studies have 
developed to understand depression, researchers remain challenged with properly 
identifying a single genetic variation that can substantially increase the risk of depression 
(Lohoff, 2010).  Recognizing that genetic variants are likely to exert just a limited 
influence to the total risk of depression, various genetic factors and environmental factors 
are reasonably causal to the progression of depression (Lohoff, 2010).  
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Health Risks Associated with Depression 
Depression can exacerbate the course of common chronic diseases (e.g., cancer, 
Parkinson’s disease, heart disease, and diabetes) by complicating the recovery phase and 
worsening the overall physical condition (CDC, 2012a).  For instance, depression can 
increase development of coronary artery disease and myocardial infarctions (Rejai et al., 
2012).  Further, negative lifestyles (e.g., smoking or consuming excessive alcohol) can 
interfere with treatment (Kenney et al., 2009).  Both physical health risks and mental 
health risks are associated with depression, which can negatively impact disease 
progression.   
For example, Penninx et al. (1998) conducted a prospective study involving 
persons aged 71 years and older, and discovered that chronically depressed persons (i.e., 
those who are depressed for at least two years) were 88% more likely to develop cancer, 
compared with non-chronically depressed elderly persons. Further, when depression was 
present for more than five years, an increased risk of cancer (e.g., stomach, rectum, liver, 
gallbladder, pancreas, lung, skin, uterus, prostate, bladder, kidney, and lymphatic) was 
present. An alternative hypothesis linking depression and cancer is due to a raised cortisol 
response to the adrenocorticotropic hormone and adrenal hypertrophy (Penninx et al., 
1998).  Depression that remains persistent over relatively long periods is an important 
factor that may link to future cancer developments (Penninx et al., 1998).   
Depression and cancer commonly co-occur.  For instance, evidence from a meta-
analysis study conducted by Pinquart and Duberstein (2010) correlated depression with 
elevated mortality in cancer patients.  Pinquart and Duberstein (2010) investigated 105 
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subjects derived from 76 prospective studies, who were an average of approximately 65 
years.  Further, 72% of the participants were women, and approximately 50% were 
married. Findings from Pinquart and Duberstein (2010) revealed that 91% of the bivariate 
associations between depression and mortality reported relative risks greater than 1.0, 
which indicates there is an association between depression and elevated mortality in 
cancer patients 
The prevalence of depression among cancer patients increases with disease 
severity and symptoms, such as pain and fatigue.  According to Gross et al. (2010), MDD 
can increase the hazard for cancer, markedly among females with breast cancer.  Gross et 
al. conducted a study on a population-based sample of 3,177 cancer-free adults from the 
Baltimore Epidemiologic Catchment Area Study, which included 24 years (i.e., adults 
followed between 1981 and 2005) of follow-up data and 334 cancer cases. Gross et al. 
(2010) concluded that a history of major depression was associated with a higher risk of 
breast cancer. Mental health and physical well-being can impact biological processes and 
outcomes (Pinquart & Duberstein, 2010). 
Treatment 
Multiple variations of antidepressants exist (e.g., selective serotonin reuptake 
inhibitors (SSRIs), norepinephrine and dopamine reuptake inhibitors (NDRIs), and 
serotonin and norepinephrine reuptake inhibitors (SNRIs); American Psychiatric 
Association, 2012a).  According to practice guidelines of the American Psychiatric 
Association (2012a), a change in dose or an augmentation of therapy is recommended for 
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patients with MDD who fail with responding to treatment or attain only limited response 
to treatment following 1 to 2 months of therapy while in the acute phase.   
Though antidepressants are the prevailing treatment for depression, two-thirds of 
people who initiate treatment fail to achieve remission (Nelson, Pikalov, & Berman, 
2008).  An initial treatment for depression typically includes SSRIs or psychotherapy, or 
both may be used in combination (Gelenberg, 2010).  However, investigators have found 
that approximately 70% of subjects with MDD who have previously encountered 
remission failure were often treated with only one antidepressant (Nelson et al., 2008).  
Considering that depression is a recurrent disease that is often inadequately treated 
(National Institute of Health, 2008), clinicians are often challenged to conform to 
treatment options to determine the most effective means by avoiding recurring episodes 
of depression in order for remission to occur. 
Risk of Recurrence 
Depression is often an episodic disease; recurring episodes of depression can 
affect nearly 50% of those who recover from their first episode (Kennedy & Giacobbe, 
2007).  The second recurrence often begins within five years from the initial episode 
(Burcusa & Iacono, 2007).  In addition, 80% of those who have a second episode are 
likely to have more episodes (American Psychiatric Association, 2012a).  Further, for 
those with a history of recurring episodes, they are likely to experience five to nine 
separate recurrent episodes over the course of their lifetime (Burcusa & Iacono, 2007). 
        The probability of recurrence escalates with each consecutive recurrent episode of 
depression (Solomon et al., 2000).  In a study involving long-term treatment for MDD, 
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Solomon et al. (2000) found that cumulative probability was 25% for subjects who had 
one recurrence at 1-year post recovery, 42% probability for recurrence at 2-year post 
recovery, and 60% probability for recurrence following 5-year post recovery (Solomon et 
al., 2000).  In addition, collective probability increased to 41% for subjects who had two 
recurrences at 1-year post recovery, 59% probability for recurrence at 2-year post 
recovery, and 74% probability for recurrence at 5-year post recovery (Solomon et al., 
2000). 
Vitamin D 
According to the Institute of Medicine (2011), vitamin D, also known as 
calciferol, is a fat-soluble vitamin that is available as a dietary supplement and produced 
endogenously. Vitamin D was originally recognized as a vitamin at the beginning of the 
20th century, but is now recognized as a prohormone that is made available in two forms 
of fat-soluble seco-sterols known as vitamin D2 or ergocalciferol, and vitamin D3 or 
cholecalciferol (Institute of Medicine, 2011).  Both forms display equivalent reactions in 
the body, and effectiveness to alleviate VDD (Institute of Medicine, 2011).   
Two forms of vitamin D (D representing D2 or D3) include vitamin D3 that is produced in 
the skin, and vitamin D2, which is made in yeast and mushrooms exposed to UVB 
radiation (Holick, 2011). Vitamin D3 and vitamin D2 are equally effective in maintaining 
vitamin D status in both children and adults (Holick et al., 2008).  However, not all 
children and adults are capable of synthesizing sufficient vitamin D levels. 
        When rays strike the epidermis and dermis, 7-dehydrocholesterol absorbs 
ultraviolet B (UVB) rays from the sun, which convert to previtamin D3.  Previtamin D3 
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then converts to vitamin D3 due to temperature dependent process (e.g., time of day, 
season during the year, latitude), aging, sunscreen use, and level of skin pigmentation 
(Holick, 2011).  Vitamin D then travels to the liver and converts to 25-hydroxyvitamin D 
[25(OH)D], also known as calcidiol (Holick, 2011). The kidneys then convert 25(OH)D 
to 1,25-hydroxyvitamin D, or calcitriol, which is the active form of vitamin D (Holick, 
2011). The active form of vitamin D, calcitriol (1,25(OH)2-vitamin D) is then induced by 
binding to its specific ligand, the vitamin D receptor (VDR) gene (i.e., a nuclear receptor 
protein that recognizes calcitriol; Holick, 2011). 
 Endogenously, vitamin D synthesis occurs when ultraviolet sunrays penetrate the 
skin and activate synthesis via hydroxylation.  Two hydroxylations occur involving 
activation for vitamin D when attained from diet, supplements, and sun exposure.  First, 
calcidiol occurs when vitamin D is converted to 25-hydroxyvitamin D [25(OH)D] in the 
liver (Institute of Medicine, 2011).  Then calcitriol occurs, which is hydroxylation formed 
by a physiologically active 1,25-dihydroxyvitamin D [1,25(OH)2D] (Institute of 
Medicine, 2011). 
        Many people and healthcare clinicians believe that sufficient vitamin D intake is 
achievable solely through diet; this belief is inaccurate (Kennel et al., 2010).  Aside from 
fatty fish, vitamin D content in most foods is relatively low (Kennel et al., 2010).  
Although both modes of vitamin D are located in dietary supplements or fortified in 
foods, only vitamin D3 synthesizes in human skin and vitamin D2 is synthetic and used as 
an additive to foods (Ross et al., 2011).  Diet alone cannot be relied upon to supply 
sufficient vitamin D intake.   
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Vitamin D and Brain Function 
Although various mechanisms for how vitamin D affect brain function have been 
proposed (Alexopoulos, 2005; Fernandes de Abreu, Eyles, & Feron, 2009; McCann & 
Ames, 2008), what remains controversial is how vitamin D protects against Parkinson 
disease.   A high vitamin D status may serve as a safeguard from developing a brain 
disease such as Parkinson’s disease (Knekt et al., 2010).  According to Knekt et al. 
(2010), persons with Parkinson’s are often found to have low serum levels of vitamin D, 
which is associated with the degeneration of dopamine neurons.   
Orme, Bhangal, and Fricker (2013) explored the development of rat ventral 
midbrains and discovered that the degeneration of dopamine neurons is causal to 
polymorphisms that occur in the VDR. Findings from Orme et al. concluded that 
polymorphisms of the VDR permit susceptibility to Parkinson’s disease (PD) and 
suggested that vitamin D3 and calcitriol may have a role with PD therapies involving 
neuroprotection.   
Calcitriol increases the number of dopamine neurons (Knekt et al., 2013) and 
enables neuroprotection by regulating neuronal concentrations of both extra and 
intracellular calcium (McCann & Ames, 2008).  Calcitriol is beneficial because it reduces 
toxicity levels due to excess calcium in neurons (Fernandes de Abreu et al., 2009; vinh 
quoc Luong & Nguyen, 2013).  VDR and hydroxylases in different areas of the brain 
confirm the existence of calcitriol (Eyles et al., 2005; Prüfer et al., 1999).  VDR and 
hydroxylases are located central to the limbic system, also known as amygdala, which is 
where emotional and behavioral regulation occur (Walbert et al., 2001).  Recent studies 
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suggest depressive symptoms and impaired cognition are associated with VDR gene 
polymorphisms (Kuningas et al., 2009).  
Although calcitriol increases the number of dopamine neurons through 
neuroprotection, habitual inadequate levels of vitamin D can result in a reduction of 
dopaminergic neurons, which raises the possibility of further progression to PD (Knekt et 
al., 2013).  Evidence by Knekt et al. (2013) exhibit that vitamin D aids in neuroprotective 
effects via neuronal calcium regulation, immunomodulation, and enhanced nerve 
conduction (Knekt et al., 2010).  Syntheses of calcium-binding proteins enables 
neuroprotection by way of inhibiting oxidation (Alexopoulos, 2005; Fernandes de Abreu 
et al., 2009; Kalueff, Eremin, & Tuohimaa, 2004; McCann & Ames, 2008).   
As a tenable biological risk factor for neuropsychiatric disorders, vitamin D 
protects brain health and provides physiologic support in preventing depression 
(Alexopoulos, 2005; Fernandes de Abreu et al., 2009; McCann & Ames, 2008). 
Moreover, vitamin D provides neuroprotection because of its ability to induce the 
synthesis of calcium-binding proteins (Alexopoulos, 2005; Fernandes de Abreu et al., 
2009; McCann & Ames, 2008). In addition, vital neurotrophic factors are regulated by 
vitamin D, which play a role in synaptic plasticity and neurotransmission (McCann & 
Ames, 2008).  Neuroprotection from vitamin D occurs when neuronal concentrations of 
calcium extra- and intracellular are regulated. Neuroprotective effects that benefit brain 
health occur via neuronal calcium regulation, immunomodulation, and enhanced nerve 
conduction (Knekt et al., 2010).  
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Benefits of Vitamin D 
Growing evidence suggests vitamin D is beneficial to a healthier brain, and can 
diminish the onset and development of depression (Hoang et al., 2011); however, the 
mechanism that connects vitamin D to mental health requires further investigation (Ganji 
et al., 2010).  Vitamin D has been shown to protect brain health, and may provide 
physiologic support in preventing depression (Alexopoulos, 2005; Fernandes de Abreu et 
al., 2009; McCann & Ames, 2008).  Vitamin D regulates vital neurotrophic factors that 
play a role in synaptic plasticity and neurotransmission (McCann & Ames, 2008).   
For instance, vitamin D manifests a neuroprotective effect by causing neutrophin 
induction to the synthesis of calcium-binding proteins, which inhibits the brain from 
producing of nitric oxide. As a result, apoptosis of neural pathways that transmit 
dopamine is prevented (Alexopoulos, 2005; Fernandes de Abreu et al., 2009; Kalueff et 
al., 2004; McCann & Ames, 2008).  Further, inflammation may contribute to depression 
as well. Vitamin D immunomodulatory activity can down-regulate inflammatory 
mediators (e.g., nuclear factor κB) that are connected to depression (Capuron et al., 2003; 
McCann & Ames, 2008).   Given the role of vitamin D in neurological processes, the 
consequences of VDD are significant; both physical and mental health consequences 
have been noted in the literature.  
Vitamin D Deficiency 
VDD is prevalent among North Americans who may not receive adequate doses 
of vitamin D through either exposure to direct sunlight or through their diets.  Forrest and 
Stuhldreher (2011), analyzed vitamin D levels in 4495 U.S. adults and determined that of 
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the 41.6% considered as vitamin D deficient, the majority were African American 
(82.1%), followed by Hispanic Americans (69.2%) (Forrest & Stuhldreher, 2011).  
Further, VDD was more common among persons with no college education, overweight, 
inadequate health status, and hypertension (all p < .001; Forrest & Stuhldreher, 2011). In 
North America, the majority of African Americans do not obtain optimal 25(OH)D 
concentrations.  This deficit stems from skin pigmentation, which reduces vitamin D skin 
production (Harris, 2006).   
It is therefore important to recognize that VDD risk differs by individual and 
differences from person to person must be considered when intervention and corrective 
action is considered.  According to Vieth (1999), the onset of VDD indicates corrective 
action should occur in the event anatomic, physiological, or biochemical abnormalities 
exist.  Corrective action entails properly administering nonpharmacological doses of 
vitamin D.  Further, the preferred method to derive vitamin D condition is to measure a 
serum concentration of 25-OH D (Holick & Chen, 2008). 
Serum 25 [OH] D is a preferred method when determining vitamin D status 
because it is an effective clinical index that is used to verify vitamin D levels that are 
stored (Milaneschi et al., 2010). Serum 25 [OH] D is an indicator for the amount of 
vitamin D retrieved through the skin and that from diet and additives (Institute of 
Medicine, 2011).  In humans, vitamin D that is in circulation as a reported half-life of 
approximately 15 days (Jones, 2008) to 30 days (Clements et al., 1992).  25(OH)D serves 
as a biomarker to sunlight exposure. However, the effect to which 25(OH)D levels 
present as a biomarker is undetermined (Institute of Medicine, 2011).  
33 
 
 
Researchers lack consensus regarding what constitutes an appropriate serum 
25(OH)D concentration cutoff (Bischoff-Ferrrari, Giovannucci, Willett, Dietrich & 
Dawson-Hughes, 2006; Dawson-Hughes et al., 2005; Ganji, Zhang, & Tangpricha, 
2012).  Individuals with serum 25-hydroxyvitamin D levels of 30.0 to 74.0 nanograms 
per milliliter (ng/mL) are found to have adequate amounts of serum 25-hydroxyvitamin D 
levels (Ganji et al., 2012).   However, the Institute of Medicine (2011) found persons at 
risk of VDD to have serum 25(OH)D concentrations of 12 ng/mL, while sufficient serum 
25(OH) vitamin D levels are found above 20 ng/mL (Institute of Medicine, 2011) and 
above 30 ng/mL (Holick & Chen, 2008).   
Yet, just as VDD poses health risks, so too do excessively high levels of vitamin 
D, or hypervitaminosis D.  Serum 25-OH D levels above 50 ng/mL are a concern for 
being too high of a level (Institute of Medicine, 2011).  According to the National 
Institute of Health (2013), doses of vitamin D exceeding 4000 units per day over several 
days may cause hypercalcemia (i.e., abnormalities with contracting muscles, releasing 
hormones and brain functioning).   Hypervitaminosis D can cause abnormally high levels 
of calcium in the blood (Kjærgaard et al., 2012).  As a result, bones, soft tissues, and 
kidneys can be damaged when there is an excess of serum 25-OH D (Kjærgaard et al., 
2012).  
Health Risk and Treatment for Vitamin D Deficiency 
In adults, VDD is linked to hypertension, cardiovascular disease, and insulin 
resistance (Saintonge, Bang, & Gerber, 2009).  According to Malabanan, Veronikis, and 
Hollick (1998), treatment of VDD in the U.S. consists of attaining a serum 25-OH D of 
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75 nmol/L, which can be accomplished by administering 50 000 IU vitamin D3 or D2 
each week for up to 8 weeks (Malabanan et al., 1998).  Further, by administering 50,000 
IU of vitamin D2 twice a month, Holick (2007) suggested subjects can maintain a 
sufficient level of serum 25-OH D of 75 nmol/L. 
The Role of Public Health Education 
Mental Health 
Behavioral health, which encompasses depression, is one of five public health 
priorities of the U.S. Department of Health and Human Services (2013).  According to 
Kessler et al. (2010), each year approximately 13 million American adults have a 
significant and debilitating mental health issue.  A goal of Healthy People 2020 (i.e., 10 
year public health objectives) is to improve mental health through prevention and by 
ensuring access to appropriate mental health services.  Despite such stated efforts, 
persons diagnosed with psychological disorders often do not obtain adequate treatment 
(Kessler et al., 2005). In addition, many who do access initial treatment fail to complete 
treatment (Edlund et al., 2006; Wang, 2007). 
  However, the prevalence of mental health and the number of people who are 
successful at gaining access and completing mental health treatment remains inversely 
proportional.  Depression is the third most common reason for people to visit a primary 
medical care clinic after hypertension and diabetes (U.S. Department of Health and 
Human Services, 2013).  Also, there is a gap that often leads to attrition for those 
requiring care.  Critical steps required to reduce unmet needs for mental health include 
receiving care that is identifiable, effective, and accessible (Pence, O’Donnell, & Gaynes, 
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2012).  Gaps in care and intervention can have significant negative consequences for 
individuals in need of treatment.    
 Gaps in service may result in attrition for those requiring care, because critical 
steps to reducing unmet needs for mental health care are often unmet. For instance, Pence 
et al. (2012) suggested the following must occur for a clinical response to positively 
impact MDD: (a) the person must enter the health care system; (b) be recognized 
clinically; (c) initiate treatment; (d) receive adequate treatment; and (e) respond to 
treatment. According to Pence et al. (2012), the primary care practitioner (PC) setting 
plays a significant role, because PC healthcare providers manage approximately two 
thirds of adults with MDD who receive treatment, while the remaining one third are 
managed by mental health experts. However, despite the amount of people with MDD 
that PC providers treat, gaps in PC settings often remain due to failures to identify, 
initiate, and provide effective treatment (Pence et al., 2012).  
According to Pence et al. (2012), patients with MDD comprise 12.5% of the PC 
population; further, 47% of this patient population with MDD are diagnosed, but of the 
24% of those treated, 9% are adequately treated, and 6% obtain remission.  However, the 
PC setting is crucial for elderly adults because patients are comfortable with discussing 
depression and treatment, which is closely monitored and coordinated by healthcare 
providers.   
Public health education can promote health by positively supporting and 
influencing individuals and communities.  Further, public health education raises 
awareness to audiences who require access and treatment to mental health services that 
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are often essential for achieving remission (Pence et al., 2012). Public health education 
may be a benefit if directed toward people with mental health disorders including 
depression, by incorporating multiple healthcare providers who specialize in mental 
disorders.  One effective public health program, which was directed toward the PC 
setting and focused on adults > 59 years with major depression, is the Improving Mood–
Promoting Access to Collaborative Treatment (IMPACT). 
A multisite randomized controlled trial involving 1801 elderly patients with MDD 
(17%), dysthymic disorder (30%), or both (53%) was conducted to determine the 
effectiveness of the IMPACT program (Unutzer et al., 2002).  The mean age was 
approximately 71 years; 23% were from ethnic minority groups (12% African American 
and 8% Latino), and 65% were women.  Nine hundred six patients representing 18 
primary care sites were randomly assigned to the IMPACT program, and 895 patients 
were assigned to usual care.  The IMPACT intervention was comprised of an initial visit 
conducted by a depression clinical specialist (DCS; e.g., nurses or psychologists) that 
involved a clinical and psychosocial history, review of educational material, and a 
discussion related to patient preference of treatment (psychotherapy or anti-depressant 
medication; Unutzer et al., 2002). 
Although final treatment choices were determined by patient and PCP, the DCS 
collaborated with PCs to review treatment plan based on a recommended algorithm (i.e., 
a choice of anti-depressant medication (serotonin-reuptake inhibitor) or a 6-8 session 
course on problem solving treatment in primary care (PST-PC).  Partial responders who 
remained depressed and were previously taking anti-depressant medication were advised 
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to increase dose or include anti-depressant medication with PST-PC.  For non-
responders, they were recommended to either adjust their medication or PST-PC.  
Patients were followed up in person or over the phone at least every two weeks.   
After 12 months of follow up from baseline, 45% of the experimental group had 50% or 
more reductions in depressive symptoms when measured with approximately 20% from 
the control care group (OR 3.45, 95% CI -1.19 to -.064; p < 0.01).  Unutzer et al. (2002) 
concluded that the IMPACT model is more advantageous and beneficial for depression 
than usual care.  The U.S. Preventive Services Task Force (2013) recommends not 
screening for depression in PC settings unless there is sufficient staff-assisted care to 
provide proper diagnosis, efficient therapy, and follow through.  Staff-assisted support as 
found with IMPACT can assist with identifying and treating depression (U.S. Preventive 
Services Task Force, 2011).   
Vitamin D  
Although depression can be identified and treated, the neurobiologic basis or 
cause for depression remains unknown (Nemeroff & Vale, 2005).  Whether levels of 
vitamin D are causal to depression, affect the outcome of depression, or has any 
relationship on depression is ambiguous among scholar practitioners (Ganji et al., 2010; 
Kjaergaard et al., 2012).  In a study conducted by Ganji et al. (2010), data was collected 
from the third NHANES to determine whether a relationship exists between serum 
vitamin D and depression.  The study consisted of 7970 participants aged 15-39 years.   
Participants from the third NHANES were evaluated through the use of the 
Diagnostic Interview Schedule.  Higher prevalence of VDD was observed by Ganji et al. 
38 
 
 
(2010) in non-Hispanic African American women, persons living below poverty, and 
persons with current depression when comparing those with adequate vitamin D 
conditions.  Ganji et al. determined that in participants with 25(OH)D ≤ 50 nmol/L the 
OR is significantly higher compared with 25(OH)D ≥ 75 nmol/L (OR = 1.85; P = 0.021).  
Ganji et al. concluded that persons with VDD are more likely to experience depression 
compared with those who are vitamin D sufficient.  Yet, consensus of whether VDD is 
causal to depression was not determined and remains inconclusive.   
Kjaergaard et al. (2012) examined the comparison of depressive symptoms in 
subjects, which were evaluated with the BDI, Hospital Anxiety and Depression Scale 
(HADS), Seasonal Pattern Assessment (SPA) scale and Montgomery Depression Rating 
(MDR) scale, and noted that in a healthy population, supplementation of high dosage 
vitamin D have no effect on depressive symptoms.  In a randomized controlled trial, 114 
participants in the control group reported high (>70nmol/l) serum 25(OH)D levels while 
243 participants in the experimental group reported low (<55 nmol/l) serum 25(OH)D 
levels; Kjaergaard  et al., 2012).  After further investigation whether D3 supplementation 
would mitigate symptoms in persons with low serum levels of 25(OH)D, Kjaergaard et 
al. concluded that low levels of vitamin D are seen as an outcome, as opposed to a cause, 
of depressive symptoms. 
However, results from Kjaergaard et al. (2012) are not universally recognized and 
accepted. Sanders et al. (2011) conducted a randomized and double-blinded trial of 
women aged ≥ 70 who were community-dwellers to examine whether supplementation of 
vitamin D can affect mood.  Over the course of 3-5 years during autumn and winter, 
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subjects randomly received placebo or 500,000 IU of vitamin D (3).   Sanders et al. 
concluded that when measuring outcomes of mental health there are no significant 
distinctions among the placebo and vitamin D groups detected.   
Although Sanders et al. (2011) concluded vitamin D is not related as an outcome 
of depressive symptoms, a previous study by Lansdowne and Provost (1988) uncovered 
that vitamin D levels can impact mental health.  Lansdowne and Provost (1988) 
examined whether vitamin D3 supplementation during winter improves mood in healthy 
subjects.  Over a period of five days, 44 participants assigned to a double-blind study 
were randomly administered 400 IU, 800 IU, or no vitamin D3. Lansdowne and Provost 
(1988) determined that vitamin D3 significantly enhanced participants’ mood, which 
resulted in a positive effect on serotonin levels, food preference, sleep, and circadian 
rhythms. 
Some authors have found high-dose vitamin D supplementation has a distinctive 
effect on depressive symptoms (Jorde et al., 2008; Kjaergaard et al., 2012; Lansdowne & 
Provost, 1988).  Jorde et al. (2008) obtained similar results noted by Lansdowne and 
Provost (1988).  Jorde et al. (2008) conducted a randomized double-blind controlled trial 
to determine the relation between 25(OH)D levels and depression.  Depression was 
measured using the BDI scores of 441 participants consisting of 159 men and 282 
women.  Subjects were provided a placebo versus 20,000 or 40,000 IU vitamin D weekly 
for 12 months.  According to Jorde et al. (2008), participants with serum 25(OH)D levels 
less than 40 nmol/l had more depressive traits, in comparison to persons with serum 
25(OH)D levels ≥ 40 nmol/l.  The placebo group did not show an improvement in BDI 
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scores. However, the two groups administered vitamin D did show significant 
improvement in depressive traits.  Jorde et al. (2008) concluded that elevated dose 
supplementation of vitamin D alleviates symptoms of depression suggesting that a causal 
relationship is possible. 
Research remains inconclusive whether VDD is an indicator for depression or 
whether depression is an indicator for VDD (Kjaergaard et al., 2012).  Additional 
research is essential to deduce the specific role, relationship, and indication of vitamin D 
in mental disorders (Kjaergaard et al., 2012).  Further, persons at risk for depression 
and/or VDD should be identified and receive intervention, because both conditions can 
negatively impact long-term health (Kjaergaard et al., 2012).  According to Kjaergaard et 
al. (2012), VDD results from depression, but is not causal.  Further, supplementation of 
vitamin D should not be used to treat depression, but rather patients who are depressed 
may be at risk of VDD.   
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Summary 
 Various mechanisms for how vitamin D plausibly impacts brain function have 
been proposed (Alexopoulos, 2005; Fernandes de Abreu et al., 2009; McCann & Ames, 
2008); but the findings have been inconsistent and not sufficiently comprehensive.  
Although recent epidemiological associations exist between vitamin D and depression 
(May et al., 2010), evidence is inclusive about whether VDD is linked to mental health 
disorders (Bertone-Johnson, 2009).  There is a paucity of information whether VDD 
precedes depression, or if depression is sub sequential to malnutrition and/or behavioral 
modifications (Bertone-Johnson, 2009).  Until further research is conducted to determine 
the association of low levels of vitamin D and the occurrence of depression, Bertone-
Johnson (2009) argued that researchers should currently refrain from concluding that 
there is a relationship between vitamin D levels and depression.   
The HBM, which postulates health action by way of preventative methods by 
engaging individuals to a healthier lifestyle, was the theoretical framework for this study 
and was incorporated to explain and predict health-related behaviors. The use of HBM 
can address why an individual may or may not adopt healthy behaviors (i.e., accept or 
reject preventative health services).  In addition, the use of HBM may address and 
uncover behaviors involving individuals with VDD and depression.   
It is well established that depression negatively impacts a person’s quality of life.  
However, what is not certain is whether a relationship exists between vitamin D levels 
and depression, nor is it clear if an existing relationship is moderated by demographic 
characteristics (gender, age, smoking status, or marital status).  The present study fills 
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gaps in the current literature because the association between depression and VDD 
remains unclear.  Because research remains inconclusive, this present study extends 
knowledge and attempts to provide social change through the use of HBM by reviewing 
efficient measures (e.g., screening and counseling) for patients with VDD to successfully 
identify if there is a relationship between vitamin D levels and depression, and if it is 
moderated by demographic characteristics (gender, age, smoking status, or marital 
status). Chapter 3 is an explanation of the methodology used to gather and interpret the 
data. 
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Chapter 3: Methodology 
Introduction 
VDD is a complex concern to the U.S. population.  Researchers consider VDD a 
pandemic that is largely caused by insufficient sun exposure, which is a large source of 
vitamin D for human beings (Holick & Chen, 2008).  However, findings on whether the 
occurrence of depression is related to serum levels of vitamin D are inconsistent 
(Bertone-Johnson, 2009).  I examined the relationship between vitamin D levels and 
depression, and how this might be moderated by an individual’s demographic 
characteristics (gender, age, smoking status, or marital status). 
Research Design and Rationale 
I conducted a quantitative, ex-post facto comparative research design as a 
framework to assess the single hypothesis.  Quantitative research incorporates causal 
paths and identifies collective strength of multiple variables (Frankfort-Nachmias & 
Nachmias, 2008).  Comparative research studies evaluate the relationship of two 
variables (Crosby, DiClemente, & Salazar, 2006).  Also, coefficient ranges measure 
correlation strength (Frankfort-Nachmias & Nachmias, 2008).  The coefficient of 
correlation is considered as Pearson’s product moment correlation coefficient, or 
Pearson’s r demonstrates a linear relationship by measuring the relation between two 
interval or ratio level variables (Frankfort-Nachmias, & Nachmias, 2008).  Three possible 
results of a comparison study could have occurred (e.g., positive correlation, a negative 
correlation, and no correlation).   
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When results indicate that variables increase or decrease simultaneously, 
suggesting a strong positive correlation exists when Pearson’s r is near +1.00, this 
constitutes as a positive correlation.  Further, a negative correlation indicates that 
variables increase or decrease non-simultaneously when Pearson’s r is near -1.00, which 
suggests there is a strong negative correlation.  However, when there is no association 
between the variables, then Pearson’s r will equate to 0.  
Comparison studies are performed to determine whether a relationship among 
variables exists.  Ex-post facto indicates that there will be no manipulation to the 
predictor variable.  In the case of this study, participants were not designated to any 
particular group considering that data was gathered and assembled by NHANES.  
Considering the purpose of this research is to obtain findings from a nationwide sample 
that represents individuals with VDD and depression throughout the U.S., I conducted a 
non-experimental study research design, as opposed to an experimental design, to 
advance knowledge in this discipline of study. 
Experimental designs enable investigators to have control over variables that are 
intrinsic and extrinsic, which strengthens internal validity (i.e., the amount of change 
recorded that is attributable to the investigation; McKenzie, Neiger, & Thackeray, 2009).  
However, experimental designs have weak external validity because investigators are 
unable to replicate real-life social conditions.  Non-experimental designs evaluate the 
status of a criterion variable by measuring pre and post the introduction of some 
treatment (Campbell & Stanley, 1963).
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Research Questions 
To guide this quantitative study, one research question was used.  The variables of 
interest included vitamin D, depression, and demographic characteristics.  The research 
question is: 
Research Question (RQ) 1:  What is the relationship between vitamin D levels 
and depression and is it moderated by demographic characteristics (gender, age, smoking 
status, or marital status)? 
H10:  There is no relationship between vitamin D levels and depression and it is 
not moderated by demographic characteristics (gender, age, smoking status, or marital 
status).  
H1A:  There is a relationship between vitamin D levels and depression and it is 
moderated by demographic characteristics (gender, age, smoking status, or marital 
status). 
Operational Model 
A structured view of the variables for Hypothesis 1 is displayed in Figure 1.  The 
predictor variable is vitamin D level, while the criterion variable is depression.  
Additionally, four moderators (age, gender, smoking status, and marital status) are stated 
as a condition.  Effect measures are presented using the characters r, R2, and R2∆. 
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Figure 1. Operational model. 
Population, Sample, and Sampling Methodology 
Population 
The study’s population will focus on adults who are at least 18 years old located 
in the U.S.  According to the U.S. Census Bureau (2013b), there are approximately 
210,316,000 individuals throughout the U.S. that fit this criterion.   
Sample 
The study’s sample consisted of adults who were at least 18 years old located in 
the United States.  To be included in the sample, adults must have taken part in NHANES 
during 2005 – 2006.  Approximately 4,773 individuals, aged 18 years and older, 
participated in the study (CDC, 2013b).  In addition, the entire data set was used in the 
study.  
Vitamin D Levels Depression R2 = ? 
Gender Age Smoking 
Status 
Marital 
Status 
R2∆ = ? R2∆ = ? R2∆ = ? R2∆ = ? 
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Sampling Methodology 
Archival data during 2005 – 2006 was extracted from the NHANES data set.  The 
entire data set was used to answer the research question.  That is, 4773 participants made 
up the sample.  A complex, multistage probability technique was used to select 
participants for the NHANES project.  The NHANES sample consisted of a 
representative sample of civilian, non-institutionalized US citizens.  The sample did not 
include individuals living in nursing homes, members of the armed forces, 
institutionalized persons, or U.S. nationals living abroad.  
Power Analysis 
Minimum sample size was derived from the power table presented by Aguinis 
(2004).  This power table offers multiple slope variations when using moderated multiple 
regression.  To obtain a power ≥ 0.80, an approximate sample size of 200 is 
recommended.  Further, Aguinis (2004) argued, in order to identify smaller regression 
slope differences, the sample size should be from 320 to 400.  Preferably, group sample 
sizes ought to be similar.  A minimum sample size of approximately 400 (i.e., 200 per 
group) was required to find a difference between regression slopes.  Given the available 
sample consisted of over 4700 participants, the minimum sample size for the study was 
met. 
Procedures 
After receiving approval from Walden University’s Institutional Review Board 
(IRB), data files were downloaded from the NHANES website.  Research organizations 
(e.g., universities, health care providers, and educators) have access to NHANES’s 
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information.  NHANES’ data (i.e., data involving serum 25[OH]D and depression) are 
available online for public use and do not require any formal permission to gain access.  
Disclaimers are indicated on the NHANES website to assure data is used solely for 
statistical analysis and health research purposes (CDC, 2013). 
The National Center for Health Statistics (NCHS) provides downloadable public-
use data files through the CDC’s file transfer protocol (FTP).  FTP supports file sharing 
by sending data electronically via Internet servers.  Users of FTP can obtain 
questionnaires, data sets, and documentation when accessing the NHANES website.  
Instructions for obtaining these data files are available by accessing Readme files, which 
are files that contain information for users to obtain basic facts (e.g., directory, contact 
information, and software information) about the program. 
Due to the extensive nature of NHANES and the amount of processing involved 
with post-data collection, data is reported to NCHS and made available biannually as 
opposed to a single point in time.  NCHS Disclosure Review Board (DRB) reviews 
documentation, edits and approves data before releasing any information on an ad hoc 
basis.  Data is often published within three months of receipt of the data. 
Instrumentation 
The NHANES program is directed by the NCHS, which is affiliated with the 
CDC (2013).  NHANES is a well-established program in the U.S. designed to monitor a 
variety of health and nutrition measurements and status of adults and children (CDC, 
2013).  The program began during the 1960s and since its existence has surveyed over 
140,000 participants in a reliable and valid format that assesses health and nutritional 
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status (CDC, 2013).  Currently, health data are also collected through the use of 
interviews, medical examinations, and sophisticated laboratory tests. 
The first three National Health Examination Surveys, (NHANES I, II and III) 
were performed periodically from 1960 to 1970 as a serial program, while between each 
portion of the survey, intervals were implemented.  Doing so permitted adequate time to 
extrapolate data (CDC, 2013).  From 1971 to 1975, a nutrition component was attached 
to a fourth series, which was included in the two prior periodic surveys performed during 
1976-1980 and 1988-1994. 
In 1999, the CDC introduced a continuous survey to increase the time required to 
release datasets and estimations concerning issues of public health interest every six 
months (CDC, 2013).  The move away from a serial survey enabled annual estimates to 
contribute to small population groups and less prevalent conditions and diseases (CDC, 
2013).  Currently, NHANES is conducted annually.  Doing so increases opportunities for 
public health practitioners to adjust survey contents to meet emerging needs (CDC, 
2013). 
The cross-sectional survey is conducted to annually examine 5,000 participants 
who make up a U.S. nationally representative sample of the non-institutionalized civilian 
population (CDC, 2013).  Participants are located and selected through a statistical 
process using the most current U.S. Census information (CDC, 2013).  Fifteen counties 
across the U.S., were randomly selected using a probability sampling technique that 
involved a complex, multistage design.  According to WHO (2013), multi-stage sampling 
involves two or more stages, where people are chosen for interviewing from a large and 
diverse population. 
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To provide evidence that may guide practical decisions, NHANES sampling 
procedure consists of four phases to ensure statistical conclusion validity.  Phase one 
involves selection of primary sampling units (PSUs), such as individual counties or a 
collection of adjoining counties that are comparable to a sizeable measure.  The second 
phase involves PSUs being detached into divisions (e.g., city blocks or their equivalent).  
In the third phase, random selection occurs for each housing unit from each 
neighborhood.  The fourth phase of the sampling procedure pertains to individuals being 
drawn within allocated screening subdomains (e.g., age-sex- ethnicity subdomains).  In 
this final stage, approximately 1.6 persons are selected per household, and an 
introductory letter is sent to a specific household member (CDC, 2013). 
All participants who consent and take part in the survey are reimbursed for time 
and travel expenses.  The survey comprises of two main entities: the home interview and 
health examination.  The interview, which takes approximately one hour, involves a 
NHANES interviewer asking questions about the participant’s diet, disease history, and 
health in participant’s home.  The interview is also conducted to collect information 
regarding demographics, socioeconomic status, and any other health related questions.  
Following the interview, participants visit a local Mobile Exam Center (MEC) where lab 
tests, body measurements, dental, and physiological assessments are conducted (CDC, 
2013). 
To expedite, simplify, and strengthen participation, transportation is granted to 
and from the MEC.  Confidentiality policies are established to prevent releasing 
inadvertent identification of individuals.  The Health Insurance Portability and 
Accountability Act of 1996 (HIPAA) Privacy and Security Rules aids in granting federal 
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protection to personal health information of participants; in addition, HIPAA also 
protects public health authorities (e.g., NHANES interviewers and examiners) and their 
role surrounding essential public health services (U.S. Department of Health & Human 
Services, 2013).  For the proposed study, the data collected in 2005-2006 will be used, 
which provides sufficiency of instrumentation to answer the research questions for the 
current study.  Since this data was previously collected, I will not make any contact with 
the participants. 
To generate reliable and valid statistics, the NHANES program overestimates 
financially challenged people, adolescents, adults ≥ 60 years, African Americans, and 
Hispanics (CDC, 2009a).  Additionally, both reliability and validity are verified by 
pretest and pilot studies conducted prior to the implementation of survey (CDC, 2009a).  
The NHANES survey was tested and retested by the CDC to ensure reliability.  Further, 
MEC interview data were recorded electronically using questionnaire forms to ensure 
reliability and validity of data (CDC, 2013). As part of the quality control process, check 
item variables were used to verify correct data was collected (CDC, 2013).  Also, during 
data preparation, variable frequency counts were checked, patterns of skipping questions 
were verified, and responses to questions were reviewed to determine response 
reasonableness (CDC, 2013).  
Operationalization of Variables 
Six variables were discussed: including one predictor variable (vitamin D level), 
one criterion variable (depression), and four moderating variables (age, gender, smoking 
status, and marital status).  The predictor and criterion variables were scaled at the 
interval level, while the moderating variables were scaled at the nominal level. 
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Vitamin D Levels 
Vitamin D levels data for NHANES 2005-2006 were first published in June, 2008 
and revised November, 2010.  For the proposed study, this data will be collected from 
SAS transport files located on the NHANES Web site.  A two-step procedure occurred 
for the laboratory assay of 25[OH]D.  First, an extraction of 25[OH]D from serum with 
acetonitrile undergoes treatment.  The treated sample is then assayed through the use of 
an equilibrium radioimmunoassay (RIA) procedure based on an antibody, which is 
specific to 25[OH]D.  After 90 minutes, at 20-25 °C, the sample, antibody, and tracer are 
incubated.  Following incubation at 20-25 °C for 20-minutes with a second antibody-
precipitating complex, phase separation occurs.  After incubation and prior to 
centrifugation, a NSB buffer is added to assist with the reduction of non-specific binding. 
For the present study, categories for Vitamin D were defined as serum 25[OH]D 
concentrations ≤ 20 ng/mL, which were used for correlation analyses (CDC, 2013b).  
Two categories included VDD (serum 25[OH]D concentrations ≤20 ng/mL; code 0) and 
vitamin D sufficient (serum 25[OH]D concentrations >20 ng/mL; code 1). 
Depression 
 The patient health questionnaire (PHQ) is a self-administered survey questionnaire 
that establishes provisional depressive disorder diagnoses and determines depressive 
symptom severity (Kroenke, Spitzer, & Williams, 2001). The PHQ was developed to 
assist primary healthcare providers make criteria-based diagnoses of DSM-IV disorders 
(e.g., mood, anxiety, somatoform, alcohol, and eating; CDC, 2013b).  The PHQ-9 is a 
questionnaire designed to specifically focus on the nine diagnostic criteria for DSM-IV 
depressive disorders.  Depression is diagnosed if a symptom answered on the 
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questionnaire is identified as depressed mood, and also if five or more of the nine 
diagnostic criteria are identified by the participant as occurring “more than half the days” 
in the previous two weeks (CDC, 2013b).  Further, depression is diagnosed if a 
participant acknowledges “thoughts that [you] would be better off dead or of hurting 
[yourself] in some way,” has occurred, regardless of the timeframe (CDC, 2013b).  The 
use of NHANES offers provisional diagnoses for depression and provides clinicians the 
ability to grade the severity of depressive symptoms (CDC, 2013b).  
For the purpose of addressing this study’s research question, the PHQ-9 
questionnaire was scored from "0" (not at all) to "3" (nearly every day).  Considering that 
there are individual questions that can score from 0 to 3, a total score for a respondent can 
range from 0 to 27.  The total score is based on cutpoints that correspond with thresholds 
(i.e., a cutpoint of 5 represents mild depression, a cutpoint of 10 represents moderate 
depression, a cutpoint of 15 represents moderately severe depression, and a cutpoint of 20 
represents severe depression).  However, for this study, a single screening of a cutpoint of 
10 or greater was used to determine major depression.  In any other study, a cutpoint less 
than 10 will indicate no depression.  A cutpoint of 10 has a specificity of 88% and 
sensitivity of 88% for MDD (Kroenke & Spitzer, 2002; Kroenke, et al., 2001).  Two 
categories for the depression variable were used, including positive diagnosis or 
depressed (code 1 for PHQ9 score >10) and negative diagnosis or not depressed (code 0 
for PHQ9 score ≤ to 10). 
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Gender 
NHANES interviewers asked all respondents whether they were male or female 
(CDC, 2013b).  This variable is scaled at the nominal level.  The two categories included: 
(a) male (code 0); and (b) female (code 1). 
Age 
A common and important confounding factor to health research is age.  Age was 
evaluated as a categorical variable.  The following five classifications of codes were used 
by the NHANES interviewer: (a) 20-29 (code 0); (b) 30-39 (code 1); (c) 40-49 (code 2); 
(d) 50-59 (code 3); and (e) > or = to 60 years (code 4) (CDC, 2013b). 
Smoking Status 
Cigarette smoking was measured on all examinees who were 18 years or older.  
However, history of alternative methods of inhaling tobacco (e.g., by way of pipe 
smoking, passive smoking, vaporizers, and cigars), were not included in the survey.  
Further, all questions pertaining to smoking were administered by interviewers via the 
Computer-Assisted Personal Interviewing-CAPI system.  Within this present study, 
respondents were categorized as not a current smoker (do not smoke at all; code 0) or a 
current smoker (smoke daily or some days; code 1). 
According to the CDC (2012a), an estimated 19% (i.e., 43.8 million) of the U.S. 
general adult population were considered as smokers in 2011.  This study’s findings may 
potentially strengthen public health through greater awareness regarding the distribution 
of cigarette smoking among individuals with VDD.  The use of CAPI assures validity of 
the data collected due to built-in edit checks when respondents answer questions.  
55 
 
 
Interviewers are alerted when abnormal responses are entered and instructed to verify 
responses. 
Marital Status   
Participants 18 years and older were inquired by interviewers of their current 
status (e.g., married, widowed, divorced, separated, never married, or living with a 
partner).  In the present study, single (e.g., unmarried, widowed, divorced, or separated; 
code 0) and married (code 1) will be used. 
Data Analysis Plan 
For the single research question, MMR analysis was incorporated.  MMR was 
used when examining the association between a predictor variable and the criterion 
variable, followed by estimating the magnitude of any effect.  MMR is a statistical 
method used for prediction and determining if there is a moderating effect (Stone & 
Hollenbeck, 1989).  The purpose of MMR is to detect the unknown value of a variable 
from the known value of two or more variables (Stone & Hollenbeck, 1989).  MMR was 
used to conduct data analysis when determining if there was a relationship between 
vitamin D levels and depression, and if the relationship was moderated by demographic 
characteristics (gender, age, smoking status, or marital status).   
Depression was the single criterion-confounding variable, while vitamin D levels 
was the predictor-confounding variable.  Further, a moderator was introduced to alter the 
relationship between other confounding variables.  This can help gauge whether a 
relationship between the predictor variable and moderator variable occurs on the criterion 
variable (Keith, 2006).  All regression models had a criterion available, predictor 
variable, and moderator(s).  The moderation variables for Hypothesis 1 were gender, age, 
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smoking status, and marital status.  As such, MMR determined if the demographic 
characteristics had an impact on the relationship between depression and vitamin D 
levels.  Utilization of MMR allowed me to determine if the predictor variable was 
correlated to the criterion variable, followed by estimating the magnitude of any effect. 
Chapter 4 contained results displayed in three discrete sections that consisted of 
the demographic, detail of analyses, and summary of results sections.  The demographic 
section consisted of a profile of participants who were part of the initial survey by 
NHANES.  The section for data analysis incorporated a thorough summary of the 
analysis conducted.  The analysis contained applicable assumptions and concluding 
inferential results.  The synopsis of results encompassed a summary of the study, study 
design, outcome and information detailed in Chapter 5.  
This analysis of data comprised of descriptive statistics, means, standard 
deviation, and frequency where appropriate.  Also, histograms, z-scores, and plots were 
displayed to support assumptions of normality.  In addition, a regression table and 
supporting figures were presented on the conditions that a relationship or affect was 
identified.  For this analysis, alpha was set at p = .05 on the condition that assumptions of 
normality were reached.  In the event there were any violations to these assumptions, the 
investigator established suitable action steps. 
Threats to Validity 
Validity pertains to the amount and type of error that may occur. Construct 
validity is a combined critique assessment of the amount, or degree, to which empirical 
data and theoretical hypotheses defend the sufficiency and suitability of translations and 
operations based on test scores or other measures of evaluation (Messick, 1990).  
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Construct validity indicates an experiment measures the construct it sets out to measure 
(Messick, 1990).  Validity can change as findings develop, making validity evidence 
serially incomplete (Grimm & Widaman, 2012). 
According to Campbell and Stanley (1963), there are two forms of threats to 
validity: external and internal.  External validity involves scientific and statistical 
generalization and internal validity involves results being affected by random and bias 
errors (Rothman, 2002).  The NHANES was designed to minimize external and internal 
validity by conducting health examinations in MECs, which provide an ideal setting for 
the collection of high quality data in a standardized environment (CDC, 2013).  All data 
files collected in MECs are merged using the common participant number (variable 
name: SEQN) to ensure information for each study participant is appropriately linked 
(CDC, 2013). Further, all questionnaires addressed by study participants are administered 
by trained household interviewers whose performance is evaluated and tested prior to 
assessing participants (CDC, 2013). 
Methodological Limitation 
To reduce the possibility of there being limitations with sample size, the 
NHANES administered in 2005-2006 included approximately 4,773 individuals, aged 18 
years and older, in the study (CDC, 2013).  Having a relatively large sample size 
strengthens the possibility of there being proper distribution of the population, to which 
results will be generalized.  Also, interview (questionnaire) data are based on self-
reported data, which is subject to non-sampling error.  To mitigate self-reported data, 
personal health data of participants are protected by HIPAA (CDC, 2012b; CDC, 2013).  
Also, to protect the confidentiality of data obtained from sample persons, masked 
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variance units (MVUs; masked variables that distinguish single counties) are constructed 
for the purpose of variance estimation (CDC, 2013). 
Further, there is a lack of prior research studies on the relationship between 
vitamin D levels and depression, and how this might be moderated by an individual’s 
demographic characteristics (gender, age, smoking status, or marital status).  This lack of 
research constitutes as a methodological limitation.  Hence, there was an important 
opportunity and need to conduct this current quantitative study for further research.  
Ethical Procedures 
The NCHS Research Ethics Review Board (ERB) verifies that NHANES follows 
ethical procedures when conducting studies.  To avoid any misunderstandings, 
participants were informed that the NHANES examination is not an alternative to routine 
primary care examinations.  Potential participants provided voluntarily consent before 
taking part in any research.  Twelve weeks after the NHANES exam, each participant 
was provided with a written report of findings.  If any abnormalities to the survey were 
detected, then a letter was immediately mailed to all participants. 
Federal law (i.e., HIPAA), and ethical obligations (i.e., the Public Health Service 
Act regarding provision 42 United States Code 242m) assures respondents strict 
confidentiality that any personal information collected by NCHS is protected (CDC, 
2012b).  To ensure that all personal information is collected and stored, restrictions were 
imposed and guidelines were implemented (CDC, 2012b).  For instance, random 
inspections by the NCHS Confidentiality Officer aid with assuring confidentiality 
standards were maintained (CDC, 2012b).   
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Also, the NCHS Associate Director for Science (ADS) has responsibility to 
review and assure adherence to restrictions pertaining to confidentiality and disclosure 
remain within compliance (CDC, 2012b).  For instance, the ADS reviewed public-use 
audio and video components (e.g., tapes, CDs, DVDs) to ensure confidentiality and 
conduct an editorial review (e.g., formatting and proper punctuation) of all products for 
efficiency (CDC, 2012b).  Protecting confidentiality of individual identifiable 
information required maintaining restrictions on how information was collected. 
To uphold such restrictions, the Public Health Service Act (Section 308 [d]) was 
passed to enforce statutorily based requirements on any data collected by the NCHS and 
CDC for the objective of obtaining analysis and reporting health statistical information 
(CDC, 2012b).  Within Section 306 of the Public Health Service Act (42 USC 242k), the 
section indicates that NCHS is authorized to collect data via telephone surveys, mail 
surveys, and electronic technology (e.g. e-mail; CDC, 2012b).  This law was passed to 
prohibit efforts of data users to determine the identity of data subjects (CDC, 2012b).  
Should any such discovery occur, notification must be communicated to NCHS (CDC, 
2012b).  Further, any identity linking data subjects from alternative NCHS or non-NCHS 
datasets is prohibited under the Public Health Service Act (CDC, 2012b).  Finally, the 
collection of data involving any personal favors, gifts, or payment to respondents is 
prohibited under this law. 
The NHANES program allows availability of downloading data in their website 
(CDC, 2013).  NHANES data files are stored in a statistical analysis software (SAS) 
transport file format (.xpt; CDC, 2013).  A SAS-accessible library is available for 
software users through the use of XPORT statements that communicate to SAS to extract 
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data from the transport file (CDC, 2013).  The latter is accomplished by using the 
XPORT engine, which is conducted in an open SAS-accessible format.  Having an open 
statistical software program available allows data collected by NCHS and CDC to remain 
vendor neutral and omit any endorsement or requirement that can be potentially solicited 
by any vendor (CDC, 2013).  SAS allows data entry, report writing, statistical analysis, 
and development of project management and operations research to occur in a safe and 
controlled format (CDC, 2013). 
Safeguarding data is of utmost importance to NCHS (CDC, 2013).  To protect 
NHANES participants’ confidentiality, the Confidential Information Protection and 
Statistical Efficiency Act (CIPSEA) was passed.  At all times, records such as names, 
addresses, and social security numbers are kept secured and locked when not in use.  
Finally, confidential records must remain within NCHS, unless assurance of 
confidentiality is transferred to a receiving party with the same protection level of 
confidentiality.  According to the CDC (2013a), measures of security (e.g., access 
control, user authentication, encryption, and access monitoring) are in place to protect 
statistical and analytical information.  The PHSA upholds strict confidentiality and was 
passed into law in order to prohibit NCHS from using or sharing any personal 
information for any purpose aside from what was described and agreed by participants 
(CDC, 2013).  Any violation of the PHSA can result in fines and imprisonment based on 
provisions set forth by the CIPSEA (CDC, 2013). 
The CIPSEA has a unique responsibility to protecting information, as does the 
NCHS, which is responsible for outlining procedures of dissemination of NHANES data 
(CDC, 2013).  NCHS disseminates public-use data files (e.g., results of epidemiologic, 
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demographic, and methodological research; CDC, 2009).  The CDC disseminates 
community health assessments and information by way of print (e.g., publications in 
peer-review journals), electronic (e.g., Listserv and e-mail), audiovisual (e.g., audio and 
broadcast scripts), and oral (e.g., formal speeches and oral presentations; CDC, 2009). 
Summary 
This quantitative study was constructed to examine the association between 
vitamin D and depression status.  The research methodology that was applied to achieve 
this purpose is specified in this chapter.  Additionally, the population and sample, data 
collection procedures, and data analysis are specified in this chapter.  Lastly, ethical 
considerations are identified to secure confidentiality and protection of those who are 
surveyed. 
An analysis of the study, explanation of the results, significance, significance of 
the results, limitations of the study, and recommendations for prospective research are 
integrated into Chapter 4.  Chapter 5 incorporates a summary of the data collected, the 
data analysis process, and the findings of the study, as they pertained to the hypotheses 
and research question. 
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Chapter 4: Results 
Introduction 
The purpose of this current quantitative study was to examine the relationship 
between vitamin D levels and depression, and how this relationship might be moderated 
by an individual’s demographic characteristics (gender, age, smoking status, or marital 
status).  The examination involved a nationwide sample of those aged 18 years and older, 
representing the U.S. population between 2005 and 2006.  One research question was 
used to guide this quantitative study.  The variables of interest included vitamin D, 
depression, and demographic characteristics. 
This chapter begins with a summary of the applied statistical methods and the 
results consisting of a detailed summary of the evaluated participants.  Next, this chapter 
presents a discussion of the descriptive statistics of the sample, and a review of the 
independent variable in relation to the criterion variable.  The description of the sample is 
followed by a discussion of the data analyses, which made use of MMR analysis to 
determine if a significant relationship between depression and vitamin D levels was 
moderated by demographic characteristics (gender, age, smoking status, or marital 
status).  Data were screened for univariate outliers, and tests for assumptions of 
normality, linearity, and homoscedasticity were conducted.  Finally, this chapter 
concludes with a summary of my findings.  
Data Collection 
Data were collected from selected individuals, aged 18 years and higher, to 
examine the relationship between vitamin D levels and depression, and how this 
relationship might be moderated by an individual’s demographic characteristics.  Data 
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collection took place between January 2005 and December 2006.  Data documenting 
vitamin D levels and depression, both with and without the covariates of gender, age, 
smoking status, or marital status were collected and analyzed using MMR. Data analyses 
were conducted on the entire data set using SPSS Statistics 22.0. 
Population and Sample 
The population of interest consisted of adults who are at least 18 years old located 
in the U.S.; approximately 210 million U.S. residents that fit this criterion.  Complex, 
multistage probability technique was used to select participants for the NHANES project 
(CDC, 2013).  The sampling procedure for the NHANES consisted of four phases to 
ensure statistical validity.  Phase one involved selection of PSUs.  The second phase 
involved PSUs being detached into divisions.  In the third phase, random selection was 
performed for each housing unit from each neighborhood.  The fourth phase of the 
sampling procedure pertained to individuals being drawn within allocated screening 
subdomains.  The multi-stage procedure was established to ensure that the sample 
consisted of a representative sample of civilian, non-institutionalized US citizens (CDC, 
2013).   
Overestimating reduced the likelihood of biased estimates occurring in this 
current study, while increasing the reliability and validity of indicator estimates of health 
status.  To reduce the occurrence of discrepancies during data collection, the NHANES 
program overestimated financially challenged people, adolescents, adults ≥ 60 years, 
African Americans, and Hispanics (CDC, 2009a).  The sample did not include 
individuals living in nursing homes, members of the armed forces, institutionalized 
persons, or U.S. nationals living abroad. 
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Data Analysis Procedure 
Inferential statistics were used to draw conclusions from the sample tested.  SPSS 
22.0 was used to code and tabulate scores collected from the survey and provide 
summarized values where applicable including the mean, central tendency, variance, and 
standard deviation.  MMR analyses were used to evaluate the research question.  The 
research question was: 
RQ 1:  What is the relationship between vitamin D levels and depression and is it 
moderated by demographic characteristics (gender, age, smoking status, or marital 
status)? 
H10:  There is no relationship between vitamin D levels and depression and it is 
not moderated by demographic characteristics (gender, age, smoking status, or marital 
status).  
H1A:  There is a relationship between vitamin D levels and depression and it is 
moderated by demographic characteristics (gender, age, smoking status, or marital 
status). 
Prior to analyzing the research question, data cleaning and data screening were 
undertaken to ensure the variables of interest met appropriate statistical assumptions.  
The following analysis was assessed using an analytic strategy in that the variables were 
first evaluated for missing data, univariate outliers, normality, linearity, and 
homoscedasticity.  Subsequently, four MMR analyses were run to determine if any 
significant relationships existed between the variables of interest.   
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Analysis of Research Question 1 
Research Question 1was evaluated using four MMR analyses to determine if a 
significant relationship existed between vitamin D levels and depression, and if the 
relationship was moderated by demographic characteristics (gender, age, smoking status, 
and marital status).  The criterion variable for the four analyses was depression as 
measured by nine-items on the Patient Health Questionnaire (PHQ).  Response 
parameters for the nine survey items were measured on a 3-point scale where 0 = not at 
all to 3 nearly every day.  Composite scores were then calculated by summing case 
responses across the nine PHQ items, resulting in scores with a possible range between 0 
and 27.  That is, higher scores indicated higher levels of depression (i.e., 5 represents 
mild depression, 10 represents moderate depression, 15 represents moderately severe 
depression, and 20 represents severe depression).   
The predictor variable for the four analyses was vitamin D levels as measured by 
the NHANES and defined in Chapter 3.  The moderating variable for Analysis 1 was 
gender (male, female).  The moderating variable for Analysis 2 was age groups (18-29 
years old, 30-39 years old, 40-49 years old, 50-59 years old, 60 years and older).  The 
moderating variable for Analysis 3 was smoking status (do not smoke at all, occasionally 
smoke).  Lastly, the moderating variable for Analysis 4 was marital status (single, 
married).   
This study’s sample consisted of 4,773 adults who were at least 18 years old 
located in the United States and had taken part in NHANES during 2005 – 2006.  The 
NHANES sample consisted of a representative sample of civilian, non-institutionalized 
US citizens, who were residing in the U.S. during the time of the study. 
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Data was collected from a valid sample of 2623 participants.  Specifically, the majority of 
participants were female (56.5%, n = 1483) and the remaining 43.5% were male (n = 
1140).  Additionally, 16.7% of the participants were between 18 and 29 years old (n = 
439), 17.9% were between 30 and 39 years old (n = 470), 19.1% were between 40 and 49 
years old (n = 501), 16.3% were between 50 and 59 years old (n = 428), and 29.9% were 
60 years and older (n = 785).  Described in Table1 are frequency and percent statistics of 
participants’ gender, marital status, and smoke status. 
Table 1 
Frequency and Percent Statistics of Participants’ Gender and Age 
Demographic Frequency Percent 
Gender   
   Male 1140 43.5 
   Female 1483 56.5 
   
Age groups   
   18 - 29 years old 439 16.7 
   30 - 39 years old 470 17.9 
   40 - 49 years old 501 19.1 
   50 - 59 years old 428 16.3 
   60 years and older 785 29.9 
Note. Total n = 2623 
Furthermore, the majority of participants were single (53.6%, n = 1217) and the 
remaining 46.4% were married (n = 1406).  Lastly, there was a similar frequency of 
participants that smoked (50.4%, n = 1323) as compared to those that do not smoke 
(49.6%, n = 1300).  Described in Table 2 are frequency and percent statistics of 
participants’ gender, marital status, and smoke status. 
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Table 2 
Frequency and Percent Statistics of Participants’ Marital Status and Smoke Status 
Demographic Frequency Percent 
Smoke Status   
   Do not smoke at all 1300 49.6 
   Smoke  1323 50.4 
   
Marital Status   
   Single 1406 53.6 
   Married 1217 46.4 
Note. Total n = 2623 
Data cleaning.  Before the analyses were evaluated, the data were screened for 
missing data, univariate outliers, and multivariate outliers.  Missing data were 
investigated using frequency counts.  Upon review, it was found that 339 participants did 
not provide their smoke status.  These participants were removed from the analysis.  The 
data were screened for univariate outliers by transforming raw scores to z-scores and 
comparing z-scores to a critical range between -3.29 and +3.29, p < .001 (Tabachnick & 
Fidell, 2007).  Z-scores that exceed this critical range are more than three standard 
deviations away from the mean and represent outliers.  The distributions of Vitamin D 
and depression were evaluated, and 54 cases with univariate outliers were found and 
removed from the analysis.  There were 3016 responses received from participants and 
2623 were evaluated by the MMR analysis (n = 2623).  Descriptive statistics for the 
criterion and predictor variables are displayed in Tables 3, 4, 5, 6, and 7. 
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Table 3 displays descriptive statistics for depression and vitamin D.  The average 
depression score was 3.93 (SD = 3.42) while the average vitamin D score was 21.47 (SD 
= 21.47).  Skewness for depression is 1.60 and skewness for vitamin D was 0.43.  
Table 3 
Descriptive Statistics of the Criterion and Predictor Variables 
Variable Min Max Mean Std. Deviation Skewness Kurtosis 
Depression 1.00 17.00 3.93 3.42 1.60 2.27 
Vitamin D 3.00 52.00 21.47 8.87 0.43 -0.14 
Note. n = 2623 
Table 4 displays descriptive statistics for depression and vitamin D by gender 
(male, female).  For males the average depression score was 3.75 (SD=3.42), while the 
average vitamin D score was 21.14 (SD = 8.32).  Skewness for depression in males was 
1.72 and skewness for vitamin D in males was 0.41. For females, skewness for 
depression was 1.52 and skewness for vitamin D was 0.43. 
Table 4 
 
Descriptive Statistics of the Criterion and Predictor Variables by Gender 
 
Variable n Min Max Mean Std. Deviation Skewness Kurtosis 
Male        
   Depression 1140 1.00 17.00 3.75 3.42 1.72 2.68 
   Vitamin D 1140 3.00 52.00 21.14 8.32 0.41 0.09 
        
Female        
   Depression 1483 1.00 17.00 4.07 3.42 1.52 2.02 
   Vitamin D 1483 3.00 52.00 21.73 9.26 0.43 -0.31 
 
Table 5 displays descriptive statistics for depression and vitamin D by age (i.e., 
18-29 years old, 30-39 years old, 40-49 years old, 50-59 years old, 60 years and older).  
For the age group 18-29 years old, the average depression score was 3.89 (SD = 3.38), 
while the average vitamin D score was 22.08 (SD= 9.35). Skewness for depression for 
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the age group 18-29 years old was 1.63 and skewness for vitamin D was 0.49.  For the 
age group 30-39 years old, the average depression score was 3.67 (SD = 3.14), while the 
average vitamin D score was 21.94 (SD = 9.22). Skewness for depression for the age 
group 30-39 years old was 1.69 and skewness for vitamin D was 0.39. For the age group 
40-49 years old, the average depression score was 4.39 (SD = 3.69), while the average 
vitamin D score was 20.66 (SD = 8.60). Skewness for depression for the age group 40-49 
years old was 1.44 and skewness for vitamin D was 0.52. For the age group 50-59 years 
old, the average depression score was 4.24 (SD = 3.77), while the average vitamin D 
score was 21.40 (SD = 8.93). Skewness for depression for the age group 50-59 years old 
was 1.54 and skewness for vitamin D was 0.36. For the age group 60 years and older, the 
average depression score was 3.65, while the average vitamin D score was 21.42. 
Skewness for depression for the age group 60 years and older was 1.62 and skewness for 
vitamin D was 0.38.  Descriptive statistics of the criterion and predictor variables by age 
group are displayed in Table 5. 
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Table 5 
 
Descriptive Statistics of the Criterion and Predictor Variables by Age Groups 
 
Variable n Min Max Mean Std. Deviation Skewness Kurtosis 
18-29 years old        
   Depression 439 1.00 17.00 3.89 3.38 1.63 2.52 
   Vitamin D 439 3.00 52.00 22.08 9.35 0.49 -0.11 
        
30-39 years old        
   Depression 470 1.00 17.00 3.67 3.14 1.69 2.80 
   Vitamin D 470 5.00 51.00 21.94 9.22 0.39 -0.22 
        
40-49 years old        
   Depression 501 1.00 17.00 4.39 3.69 1.44 1.61 
   Vitamin D 501 4.00 50.00 20.66 8.60 0.52 0.07 
        
50-59 years old        
   Depression 428 1.00 17.00 4.24 3.77 1.54 1.81 
   Vitamin D 428 5.00 51.00 21.40 8.93 0.36 -0.39 
        
60 years and older        
   Depression 785 1.00 17.00 3.65 3.19 1.62 2.40 
   Vitamin D 785 3.00 52.00 21.42 8.48 0.38 -0.14 
 
 
Table 6 displays descriptive statistics for depression and vitamin D by smoking 
status (do not smoke at all, smoke).  For non-smokers, the average depression score was 
4.26 (SD = 3.67), while the average vitamin D score was 21.87 (SD = 8.90).  Skewness 
for depression in non-smokers was 1.45 and skewness for vitamin D in non-smokers was 
0.39. For smokers, the average depression score was 3.61 (SD = 3.13), while the average 
vitamin D score was 21.09 (SD = 8.82).  Skewness for depression in smokers was 1.75 
and skewness for vitamin D in smokers was 0.47. Descriptive statistics of the criterion 
and predictor variables by smoking status are displayed in Table 6. 
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Table 6 
 
Descriptive Statistics of the Criterion and Predictor Variables by Smoking Status 
 
 
 
Table 7 displays descriptive statistics for depression and vitamin D by marital 
status (single, married).  For single, the average depression score was 3.69 (SD = 3.23), 
while the average vitamin D score was 22.60 (SD = 8.66).  Skewness for depression in 
single was 1.61 and skewness for vitamin D in single was 0.33. For married, the average 
depression score was 4.22 (SD = 3.61), while the average vitamin D score was 20.18 (SD 
= 8.93).  Skewness for depression in married was 1.56 and skewness for vitamin D in 
married was 0.59. Descriptive statistics of the criterion and predictor variables by marital 
status are displayed in Table 7. 
Table 7 
 
Descriptive Statistics of the Criterion and Predictor Variables by Marital Status 
Variable n Min Max Mean Std. Deviation Skewness Kurtosis 
Single        
   Depression 1406 1.00 17.00 3.69 3.23 1.61 2.34 
   Vitamin D 1406 5.00 52.00 22.60 8.66 0.33 -0.16 
        
Married        
   Depression 1217 1.00 17.00 4.22 3.61 1.56 2.04 
   Vitamin D 1217 3.00 52.00 20.18 8.93 0.59 0.04 
 
 
Variable n Min Max Mean Std. Deviation Skewness Kurtosis 
Do not smoke at all        
   Depression 1300 1.00 17.00 4.26 3.67 1.45 1.48 
   Vitamin D 1300 3.00 52.00 21.87 8.90 0.39 -0.22 
        
Smoke        
   Depression 1323 1.00 17.00 3.61 3.13 1.75 3.29 
   Vitamin D 1323 3.00 51.00 21.09 8.82 0.47 -0.04 
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Test of normality.  Before Analyses 1-4 were conducted, basic parametric 
assumptions were assessed.  That is, for the criterion variable (depression) and predictor 
variable (vitamin D), assumptions of normality, linearity, and homoscedasticity were 
tested.  Linearity and homoscedasticity were evaluated using scatterplots, and no 
violations were observed.  To test if the distributions were significantly skewed, the skew 
coefficients were divided by the skew standard error, resulting in a z-skew coefficient.  
This technique was recommended by Tabachnick and Fidell (2007).  Specifically, z-skew 
coefficients exceeding the critical range between -3.29 and +3.29 (p < .001) may indicate 
non-normality.  Based on the evaluation of the z-skew coefficients, distributions for both 
the criterion and predictor variables exceeded the critical range (depression z-skew = 
33.35 and vitamin D z-skew = 9.00).   
Kurtosis was also evaluated using the same method, and the distribution of the 
criterion variable (depression) was found to be significantly kurtotic (z-kurtosis = 23.68).  
Although the distributions were significantly skewed and kurtotic, according to the 
central limit theorem, sample sizes of 30 or more approximates the mean of the 
population (Durrett, 2004).  With this in mind, Tabachnick and Fidell (2007) posited that 
when a sample size exceeds 100, statistical tests that use the general linear model, such as 
regression and analysis of variance, are robust against violations of normality.  The 
distributions were conditionally assumed to be normally distributed.  Displayed in Table 
8 are skewness and kurtosis statistics of the criterion and predictor variables.   
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Table 8 
Skewness and Kurtosis Statistics of the Criterion and Predictor Variables 
Variable n Skewness Skew Std. Error z-skew Kurtosis 
Kurtosis 
Std. Error z-kurtosis 
Depression 2623 1.60 0.05 33.35 2.27 0.10 23.68 
Vitamin D 2623 0.43 0.05 9.00 -0.14 0.10 -1.44 
Note. n = 2623 
 
ANOVA Analyses 
 Two analyses of variance (ANOVA) were conducted to determine if there were 
significant differences in depression and vitamin D between gender, age, smoking status, 
and marital status.  Specifically, analysis 1 evaluated differences in depression 
(dependent variable) and analysis 2 evaluated differences in vitamin D levels (dependent 
variable).  The independent variables were gender (male, female), age (18-29 years old, 
30-39 years old, 40-49 years old, 50-59 years old, 60 years and older), smoking status (do 
not smoke at all, occasionally smoke), and marital status (single, married). 
ANOVA Analysis 1 
Using SPSS 22, ANOVA was conducted to determine if a significant difference 
in depression existed between gender, age, smoking status, and marital status.  Results 
indicated that a significant difference did exist between gender (p < .001), age (p = .001), 
smoking status (p < .001), and marital status (p < .001).  That is, females had 
significantly higher depression scores (M = 4.07, SD = 3.42) than males (M = 3.75, SD = 
3.42).  For age, results from a Tukey post-hoc analysis indicated that there were several 
significant differences between age groups.  Specifically, participants between 40 and 49 
years old (M = 4.39, SD = 3.69) had significantly higher depression scores than 
participants between 30 and 39 years old (M = 3.67 SD = 3.14, p = .008) and participants 
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60 years and older (M = 3.65, SD = 3.19, p = .001)—see Table 15 in Appendix A for 
summary details of the post-hoc analysis.  Additionally, participants between 50 and 59 
years old (M = 4.24, SD = 3.77) had significantly higher depression scores than 
participants 60 years and older (p = .030).  Furthermore, participants that did not smoke 
had significantly higher depression scores (M = 4.26, SD = 3.67) as compared to those 
that do not smoke (M = 3.61, SD = 3.13).  Lastly, married participants had significantly 
higher depression scores (M = 4.22, SD = 3.61) than single participants (M = 3.69, SD = 
3.23).  A model summary of the ANOVA analysis is displayed in Table 9. 
Table 9 
Model Summary of ANOVA Analysis of Analysis 1 
Source Type III Sum of Squares df Mean Square F Sig.(p) 
Partial Eta 
Squared 
Observed 
Power 
Corrected Model 1216.092 39 31.182 2.731 < .001 .040 1.000 
Intercept 35221.613 1 35221.613 3084.417 < .001 .544 1.000 
Gender 141.868 1 141.868 12.424 < .001 .005 .941 
Age 223.354 4 55.839 4.890 .001 .008 .960 
Smoke Status 377.096 1 377.096 33.023 < .001 .013 1.000 
Marital Status 156.137 1 156.137 13.673 < .001 .005 .959 
Error 29495.828 2583 11.419     
Total 71268.000 2623      
Corrected Total 30711.921 2622           
Note. Dependent variable = depression 
ANOVA Analysis 2 
ANOVA was conducted to determine if a significant difference in vitamin D 
levels existed between gender, age, smoking status, and marital status.  Results indicated 
that a significant difference did exist between gender (sig. = .004), smoking status (p = 
.001), and marital status (p < .001).  That is, females had significantly higher vitamin D 
levels (M = 21.73, SD = 9.26) than males (M = 21.14, SD = 8.32).  Furthermore, 
participants that did not smoke had significantly higher vitamin D levels (M = 21.87, SD 
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= 8.90) as compared to those that do not smoke (M = 21.09, SD = 8.82).  Lastly, single 
participants had significantly higher vitamin D levels (M = 22.60, SD = 8.66) than 
married participants (M = 20.18, SD = 8.93).  There were no significant differences in 
vitamin D levels between age groups (p = .313).  A model summary of ANOVA Analysis 
of Analysis 2 is displayed in Table 10. 
Table 10 
Model Summary of ANOVA Analysis of Analysis 2 
Source Type III Sum of Squares df Mean Square F Sig.(p) 
Partial 
Eta 
Squared 
Observed 
Power 
Corrected Model 10972.316 39 281.341 3.725 < .001 .053 1.000 
Intercept 1029044.010 1 1029044.010 13624.755 < .001 .841 1.000 
Gender 628.105 1 628.105 8.316 .004 .003 .822 
Age 359.364 4 89.841 1.190 .313 .002 .377 
Smoke Status 878.370 1 878.370 11.630 .001 .004 .926 
Marital Status 3102.214 1 3102.214 41.074 < .001 .016 1.000 
Error 195087.592 2583 75.528     
Total 1415555.000 2623      
Corrected Total 206059.909 2622           
Note. Dependent variable = vitamin D 
Results Analysis 1 
Using SPSS 22.0, Analysis 1was evaluated using regression and moderated 
multiple regression (MMR) analysis to determine if a significant relationship existed 
between depression and vitamin D levels, and if that relationship was moderated by 
gender.  Regression analysis was used to determine if a significant relationship existed 
between depression and vitamin D.  Results indicated that a significant, negative 
relationship did exist between participants’ depression and vitamin D, R = .075, R2 = 
.006, F(1, 2621) = 14.703, sig. (p) < .001.  A model summary of the regression analysis is 
displayed in Table 11. 
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Table 11 
Model Summary of Regression Analysis  
Source R R2 Standard Error F Sig. (p) 
Omnibus Model .075 .006 3.414 14.703 < .001 
      
      
 Unstandardized Coefficients 
Standardized 
Coefficients   
Source B Std. Error Beta t Sig. (p) 
(Constant) 4.551 0.175  26.053 < .001 
Vitamin D -0.029 0.008 -0.075 -3.835 < .001 
Note. Dependent variable = depression 
MMR was used to test if gender moderated the relationship between vitamin D 
and depression. MMR Results indicated that there was a significant relationship between 
depression and vitamin D levels, R = .09, R2 = .01, F(2, 2620) = 10.59, p < .001; 
however, results indicated that the relationship between depression and vitamin D was 
not significantly moderated by gender, ∆R2 = .001, ∆F(1, 2619) = 2.60, ∆sig. (p)  = .11 
(two-tailed).  A model summary of the MMR for Analysis 1 is displayed in Table 12.  
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Table 12 
Model Summary Generated from Moderated Multiple Regression Analysis 1 
Model R R2 ∆R2 ∆F df1 df2 ∆F Sig. (p) 
1 .09 .01 .01 10.59 2 2620 < .001 
2 .10 .01 < .01 2.60 1 2619 .11 
        
 Unstandardized  Standardized    
Variable B S.E.   Beta t Sig. (p) Partial Correlation 
Model 1        
   (Constant) 4.03 0.27   14.97 < .001  
   Vitamin D -0.03 0.01  -0.08 -3.92 < .001 -0.08 
   Gender 0.34 0.13  0.05 2.54 0.01 0.05 
        
Model 2        
   (Constant) 3.17 0.60   5.32 < .001  
   Vitamin D 0.01 0.03  0.03 0.42 0.68 0.01 
   Gender 0.87 0.36  0.13 2.45 0.01 0.05 
   Interaction 1 -0.03 0.02   -0.14 -1.61 0.11 -0.03 
Note. Dependent variable = depression 
          Interaction 1 = vitamin D * gender 
 
Results Analysis 2 
Analysis 2 was evaluated using MMR analysis to determine if the significant 
relationship between depression and vitamin D levels was moderated by age groups (18-
29 years old, 30-39 years old, 40-49 years old, 50-59 years old, 60 years and older).  As 
found in Analysis 1, there was a significant relationship between depression and vitamin 
D levels, R = .08, R2 = .01, F(2, 2620) = 7.58, p < .01; however, results indicated that the 
relationship between depression and vitamin D was not significantly moderated by age 
groups, ∆R2 < .001, ∆F(1, 2619) = 0.54, ∆sig.(p) = .46 (two-tailed).  A model summary 
of the MMR for Analysis 2 is displayed in Table 13. 
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Table 13 
Model Summary Generated from Moderated Multiple Regression Analysis 2 
Model R R2 ∆R2 ∆F df1 df2 ∆F Sig. (p) 
1 .08 .01 .01 7.58 2 2620 < .01 
2 .08 .01 < .001 0.54 1 2619 .46 
        
 Unstandardized  Standardized    
Covariate B S.E.   Beta t Sig. (p) Partial Correlation 
Model 1        
   (Constant) 4.65 0.23   20.10 < .001  
   Vitamin D -0.03 0.01  -0.08 -3.85 < .001 -0.08 
   Age groups -0.03 0.05  -0.01 -0.68 0.50 -0.01 
        
Model 2        
   (Constant) 4.40 0.42   10.47 < .001  
   Vitamin D -0.02 0.02  -0.05 -0.97 0.33 -0.02 
   Age groups 0.05 0.12  0.02 0.42 0.67 0.01 
   Interaction 2 < 0.01 0.01   -0.05 -0.73 0.46 -0.01 
Note. Dependent variable = depression 
          Interaction 2 = vitamin D * age groups 
 
Results Analysis 3 
Analysis 3 was evaluated using MMR analysis to determine if the significant 
relationship between depression and vitamin D levels was moderated by smoke status (do 
not smoke at all, occasionally smoke).  As found in Analyses 1 and 2, there was a 
significant relationship between depression and vitamin D levels, R = .12, R2 = .02, F(2, 
2620) = 20.59, p < .001.  However, results indicated that the relationship between 
depression and vitamin D was not significantly moderated by smoke status, ∆R2 < .001, 
∆F(1, 2619) = 1.04, ∆sig.(p)  = .31 (2-tailed).  A model summary of the MMR for 
Analysis 3 is displayed in Table 14. 
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Table 14 
Model Summary Generated from Moderated Multiple Regression Analysis 3 
Model R R2 ∆R2 ∆F df1 df2 ∆F Sig (p). 
1 .12 .02 .02 20.59 2 2620 < .001 
2 .13 .02 < .001 1.04 1 2619 .31 
        
 Unstandardized  Standardized    
Covariate B S.E.   Beta t Sig. (p) Partial Correlation 
Model 1        
   (Constant) 5.61 0.27   20.77 < .001  
   Vitamin D -0.03 0.01  -0.08 -4.08 < .001 -.08 
   Smoke Status -0.68 0.13  -0.10 -5.13 < .001 -.10 
        
Model 2        
   (Constant) 6.11 0.56   10.99 < .001  
   Vitamin D -0.05 0.02  -0.14 -2.25 .02 -.04 
   Smoke Status -1.01 0.35  -0.15 -2.90 < .01 -.06 
   Interaction 3 0.02 0.02   0.08 1.02 .31 .02 
Note. Dependent variable = depression 
          Interaction 3 = vitamin D * smoke status 
 
Results Analysis 4 
Analysis 4 was evaluated using MMR analysis to determine if the significant 
relationship between depression and vitamin D levels was moderated by marital status 
(single, married).  As found in Analyses 1-3, there was a significant relationship between 
depression and vitamin D levels, R = .10, R2 = .01, F(2, 2620) = 13.48, p < .001.  
However, results indicated that the relationship between depression and vitamin D was 
not significantly moderated by marital status, ∆R2 < .001, ∆F(1, 2619) = 1.27, ∆sig.(p) = 
.26 (two-tailed).  The null hypothesis was partially retained.  That is, there was a 
significant relationship between vitamin D levels and depression, however the 
relationship was not moderated by demographic characteristics (gender, age, smoking 
status, or marital status).   A model summary of the MMR for Analysis 4 is displayed in 
Table 15. 
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Table 15 
Model Summary Generated from Moderated Multiple Regression Analysis 4 
Model R R2 ∆R2 ∆F df1 df2 ∆F Sig.(p) 
1 .10 .01 .01 13.48 2 2620 < .001 
2 .10 .01 < .001 1.27 1 2619 .26 
        
 Unstandardized  Standardized    
Covariate B S.E.   Beta t Sig. (p) Partial Correlation 
Model 1        
   (Constant) 3.79 0.28   13.52 < .001  
   Vitamin D -0.03 0.01  -0.07 -3.33 < .001 -.07 
   Marital Status 0.47 0.14  0.07 3.49 < .001 .07 
        
Model 2        
   (Constant) 4.34 0.56   7.71 < .001  
   Vitamin D -0.05 0.02  -0.13 -2.14 .03 -.04 
   Marital Status 0.11 0.35  0.02 0.30 .76 .01 
   Interaction 4 0.02 0.02   0.08 1.13 .26 .02 
Note. Dependent variable = depression 
          Interaction 4 = vitamin D * marital status 
 
A final model was generated to observe the association between vitamin D and 
depression after controlling for age, marital status, gender, and smoke status.  Sequential 
regression was used to test the final model where block 1 contained the four covariates, 
and block 2 added vitamin D.  Sequential regression is used to examine r-squared change 
to determine if an association exists between vitamin D and depression after controlling 
for the effects of the covariate.  Based on findings, a significant relationship was found 
between vitamin D and depression after controlling for the effects of age, marital status, 
gender, and smoke status; ∆R2 = .01, ∆F(1, 2619) = 14.34, ∆Sig. (p). < .001 (two-tailed) 
A model summary of the final model is displayed in Table 16. 
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Table 16 
Final Model Summary Generated from Sequential Multiple Regression Analysis  
Model R R2 ∆R2 ∆F df1 df2 ∆F Sig.(p) 
1 0.14 0.02 0.02 12.96 4 2620 < .001 
2 0.16 0.03 0.01 14.34 1 2619 < .001 
        
 Unstandardized  Standardized    
Covariate B S.E.   Beta t Sig. (p) Partial Correlation 
Model 1        
   (Constant) 3.79 0.44   8.65 < .001  
   Gender 0.64 0.16  0.08 4.10 < .001 .08 
   Smoke Status -0.80 0.15  -0.11 -5.37 < .001 -.10 
   Marital Status 0.72 0.15  0.09 4.77 < .001 .09 
   Age -0.01 < .01  -0.05 -2.34 .02 -.05 
        
Model 2        
   (Constant) 4.72 0.49   9.73 < .001  
   Gender 0.68 0.16  0.09 4.37 < .001 .08 
   Smoke Status -0.84 0.15  -0.11 -5.66 < .001 -.11 
   Marital Status 0.63 0.15  0.08 4.12 < .001 .08 
   Age -0.01 < .01  -0.05 -2.46 .01 -.05 
   Vitamin D -0.04 0.01   -0.09 -4.40 < .001 -.09 
Note: Dependent Variable = Depression 
 
Summary 
In summary, vitamin D is essential to optimizing health and preventing disease 
(Bertone-Johnson, 2009).  Therefore, there is a need to determine whether VDD is 
physiologically correlated to the occurrence of depression (Bertone-Johnson, 2009).  My 
intent for researching this current study was to explore whether there is a relationship 
between vitamin D levels and depression, and how this might be moderated by an 
individual’s demographic characteristics such as gender, age, smoking status, or marital 
status.   
The ex-post facto exploratory MMR analysis of this current study indicated that 
there was a significant relationship between vitamin D levels and depression; however 
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the relationship was not moderated by demographic characteristics (gender, age, smoking 
status, or marital status).  Table 17 provides a summary of the results for all analyses.  
There were no statistically significant relationships between any of the predictor 
variables, concluding that the predictor variables and the interaction effects do not have a 
significant effect on the outcome variable.  In Chapter 5, I provide a detailed discussion 
of these results.  Additionally, I present study limitations, recommendations for future 
studies, and implications for social change. The final model, though did find a significant 
relationship between vitamin D and depression after controlling for the four covariates.  
Table 17 
Summary of Results for Analyses 1-4 
Hypothesis Criterion Variable Predictor Variable Moderator Test ∆ Sig.(p) 
1  Depression Vitamin D Levels Gender Moderated Multiple Regression .11 
2 Depression Vitamin D Levels Age Groups Moderated Multiple Regression .46 
3 Depression Vitamin D Levels Smoke Status Moderated Multiple Regression .31 
4 Depression Vitamin D Levels Marital Status Moderated Multiple Regression .26 
Final 
Model Depression Vitamin D Levels 
Gender, Age, 
Smoke, and 
Marital Status 
Sequential 
Regression < .001 
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Chapter 5: Discussion 
Introduction 
The purpose of this current quantitative study was to examine the relationship 
between vitamin D levels and depression, and how this relationship might be moderated 
by an individual’s demographic characteristics (gender, age, smoking status, or marital 
status).  Results of the analyses indicate that vitamin D levels are associated with 
depression. Yet, following the adjustment of demographic characteristics, the relationship 
between vitamin D levels and depression was not moderated by demographic 
characteristics (gender, age, smoking status, or marital status). The findings of this study 
contribute to the existing body of literature that has explored the implications of VDD in 
relation to mental health by confirming the correlation with depression and indicating that 
this finding did not vary by the selected moderating variables of gender, age, smoking 
status, or marital status.   
Many studies have researched the relationship of vitamin D status in persons with 
depression. However, to date, the results of these studies remain controversial (Bertone-
Johnson, 2009; Harris & Dawson-Hughes, 1993; Kwasky, & Groh, 2012; Schneider, 
Weber, Frensch, Stein, & Fritze, 2000). Prior to the current study, no published research 
has explored the association between vitamin D levels and depression by determining if 
this relationship is moderated by demographic characteristics (gender, age, smoking 
status, or marital status).  My purpose was to highlight original research by offering a 
new perspective to the field of public health. 
This current study provides evidence-based research to support the 
implementation and achievement of the 10-year national objectives set forth by 
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HealthyPeople 2020, which is a strategic plan for improving the health of all Americans. 
As the federal government continues to enhance health reform legislation, this study can 
provide direction to persons with VDD and depression and their providers, including new 
screening opportunities and education services that empower individuals to make 
informed health decisions. 
Bertone-Johnson (2009) conducted a meta-analysis that investigated primary 
research literature that suggested and refuted whether serum vitamin D and depression 
are associated.  Bertone-Johnson completed the study without conclusion and 
recommended further research.  Further, Bertone-Johnson cautioned that it was premature 
to relate the occurrence of depression to vitamin D status and that many cross-sectional 
studies have presented unadjusted results not taking into consideration confounders (e.g., 
age, time spent outdoors, latitude, physical activity, body mass index, smoking and 
alcohol use; Brot, Jorgensen, & Sorensen, 1999; Gerdhem, Ringsberg, Obrant, & 
Akesson, 2005; Holick, 2008; Santori et al., 2008).  These same confounders are also 
associated with depression and vitamin D status (Jané-Llopis & Matytsina, 2006; Pasco 
et al., 2008; Roberts, Kaplan, Shema, & Strawbridge, 1997). Researchers have not been 
able to determine whether these associations occur from confounders (Michelson et al., 
1996; Schneider et al., 2000; Wilkins, Sheline, Roe, Birge, & Morris, 2006). 
Each year nearly 13 million adults in the U.S. experience depression, a serious 
and disabling mental health issue causing social distress and impaired quality of life 
(Kessler et al., 2010). According to the CDC (2011b), from 2001 to 2006, approximately 
33% of the U.S. population was at risk of having low levels of vitamin D (serum 25OHD 
30–49 nmol/L), while approximately 8% were at risk of VDD (serum 25OHD less than 
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30 nmol/L).  Further, the prevalence was higher in persons who were adult, female, or 
minority (CDC, 2011b).  This study was conducted to determine if statistical and 
theoretical support should be applied for the association of vitamin D levels and 
depression.  Although there is evidence that Vitamin D is vital to enhancing health and 
reducing the risk of disease (Bertone-Johnson, 2009), there is a paucity of research 
whether VDD is physiologically related to the occurrence of depression (Bertone-
Johnson, 2009).  This study was conducted to explore whether there is a relationship 
between vitamin D levels and depression, and how this might be moderated by an 
individual’s demographic characteristics such as gender, age, smoking status, or marital 
status.   
This present study was developed according to a quantitative, ex-post facto 
comparative research design.  Medical, mental, and laboratory results were derived from 
2005-2006 NHANES data (CDC, 2013). The study’s sample consisted of adults at least 
18 years old, resided in the U.S., and had taken part of the NHANES in 2005 – 2006.  
The single research question for this present study integrated a MMR analysis to 
determine the effect of a predictor variable (VDD) on a criterion variable (depression), is 
dependent on the moderators (gender, age, smoking status, and marital status).  
Moderators were introduced to explore if the demographic characteristics impact the 
relationship between depression and vitamin D levels, which helped determine that the 
predictor variable was correlated to the criterion variable.  Further, I would have been 
able to determine the magnitude of any effect if the moderating variables had exerted 
influence on the correlation. 
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Summary of Findings 
In this study, a sample of 2623 adults located within the United States were 
evaluated.  Data was entered into SPSS 22.0 and were then tested using MMR analysis to 
evaluate the research question.  The research question was, What is the relationship 
between vitamin D levels and depression and is it moderated by demographic 
characteristics (gender, age, smoking status, or marital status)? 
Results of Research Hypothesis 1 
H10:  There is no relationship between vitamin D levels and depression, and it is 
not moderated by demographic characteristics (gender, age, smoking status, or marital 
status).  
H1A:  There is a relationship between vitamin D levels and depression, and it is 
moderated by demographic characteristics (gender, age, smoking status, or marital 
status). 
Using SPSS 22.0, Hypothesis 1 was evaluated using four MMR analyses to 
determine if a significant relationship existed between vitamin D levels and depression, 
and if the relationship was moderated by demographic characteristics (gender, age, 
smoking status, and marital status).  Results from Analyses 1-4 indicated that there was a 
significant relationship between depression and vitamin D levels (p < .001).  However, 
the relationship between depression and vitamin D was not significantly moderated by 
gender (∆p = .11), age (∆p = .46), smoke status (∆p = .31), or marital status (∆p = .26).  
The null hypothesis for the Research Question was rejected in part and retained in part.  
Though a correlation was found between vitamin D and depression, the moderating 
variables did not exert influence.   
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This data represents new findings that contribute to the literature on addressing 
VDD and depression, which may further lead investigators to lower the rates of both 
adverse health conditions. Further, inconsistencies in the prior research stem from a 
failure to identify any possible significant differences in this relationship by gender, age, 
smoking status, or marital status.  This current study has the potential to assist public 
health practitioners in promoting prevention strategies and developing appropriate 
intervention strategies designed to address at risk individuals with VDD and depression. 
The findings of this study are significant for determining the relationship between 
vitamin D levels and depression, which can assist with distinguishing groups at risk of 
VDD and depression and measures to target solutions directed toward these particular 
individuals. The model in this study supports prior research that had also affirmed a 
correlation between vitamin D levels and depression (Jorde et al., 2008; Kjaergaard et al., 
2012; Lansdowne & Provost, 1988).    
Strengths of the Study 
The current study obtained data from a nationally representative multistage, 
random sample of non-institutionalized individuals who reported being 18 years or older 
at the time of data collection. The survey set files were in SAS transport file format, 
which were used to account for complex probability and proper analysis of the data that 
specifically incorporated sample design complications such as weighting and clustering. 
Data for the study was obtained from NHANES 2005-2006. Analytic guidelines were 
followed to monitor weighting, variance estimation, and sample design to ensure 
recommended methodologies were compliant when obtaining survey estimates, 
computing sample variances, and recommending sample sizes for analysis.  Further, 
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through the protection of public health laws, all data collected is private and strictly 
confidential. 
Limitations of the Study 
As with most research, the results of this study are constrained by a number of 
limitations that must be acknowledged.  Though these limitations must be considered in 
relation to the study findings, the conclusions of the study make a valuable contribution 
to the existing body of literature on this subject.  First, it must be noted that the causal 
relationship between VDD or vitamin D levels cannot be established based on the nature 
of the MMR analysis.  Kjaergaard et al. (2012) indicated that the association between 
VDD and depression could be bidirectional, which suggests more research is needed to 
determine causality.    
Generalizability 
 This study targeted only non-institutionalized adults over the age of 18 years; this 
may have impacted the generalizability of my results because of partial representation.  
The sample consisted of non-institutionalized civilian adults who were at least 18 years 
old, resided in the U.S and had taken part of the NHANES in 2005 – 2006.  In addition, I 
cannot determine whether there are limitations to NHANES ability to estimate population 
trends that are pertinent. Therefore, these findings may not be generalizable to other 
populations.   
Validity 
This current study’s assessment was conducted using the PHQ-9 questionnaire, a 
screening and diagnostic instrument, which measures depression. According to Kroenke 
et al. (2001), the PHQ enables provisional depressive disorder diagnoses and establishes 
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depressive symptom severity.  Data from the PHQ-9 were collected to determine a 
respondents’ major depression score according to the respondents’ self-reported 
retrospective perception. Although the CDC (2013) considers the PHQ a reliable and 
valid tool for diagnosing depression, concerns with validity should be considered because 
perceptions of oneself may be different than reality, as seen by the interviewer or others. 
Although PHQ-9 is a useful screening instrument and is efficient for assessing a general 
population (Inoue et al., 2012), research validating the specificity of the PHQ-9 
questionnaire remains unavailable (Kroenke et al., 2001).   
Reliability  
NHANES is a reliable reference that is dependable, accurate, and honest (CDC, 
2013). Federal agencies (e.g., the National Institutes of Health, the Food and Drug 
Administration, and CDC) formulate and implement national health policy agendas and 
resource allocation activities. Such research centers depend on NHANES to develop and 
disseminate data necessary for planning and executing public health activities (Novick, 
Morrow, & Mays, 2008).  As a reliable source of national-level prevalence and tends of 
selected diseases and risk factors, NHANES facilities community health planning and 
monitoring prevention effectiveness. To generate reliable statistics, over-sampling 
occurred to adjust the class distribution of the data set.  As a means to control reliability, 
a U.S. national representation of those 18 years and older, (i.e., persons 60 and older, 
African American, and Hispanics) were over-sampled to ensure that there were enough 
respondents reporting for this group. 
However, the use of secondary data increases the probability of measurement 
error and data variance.  Error can occur due to constructs and content validity of the data 
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collected. Further, standard concept error could have presented errors to invalidate 
secondary data. For instance, the PHQ-9 questionnaire has limited control over reliability, 
because healthcare clinicians were not onsite to assess clinical findings for depression.  
Further, the PHQ-9 questionnaire has limited control over reliability because the 
instrument is not applicable for diagnosing current depressive episodes a participant may 
be experiencing while taking the questionnaire (Kroenke et al., 2001).  Further, deception 
can occur to avoid embarrassment in answering questions truthfully when answering the 
PHQ-9 questionnaire. Participants may have been improperly classified as not having 
depression, which may impact this present study’s reliability. 
Also, my actions and attitude when collecting the data could have played a role in 
measurement error (i.e., deviating from the true value’s outcome when measuring 
results).  Finally, lag time may have played a role with increasing measurement error and 
data variance due to the time that primary data was collected is different that the time the 
data was published.  For instance, in this study participants were examined for depression 
and vitamin D levels in 2005 and 2006; however, results were not published until 2008 
and updated in 2010, respectively.  
Further, to produce reliable statistics, the CDC tested and retested the NHANES 
data and the information collected during MEC interviews were electronically recorded.  
Also, quality control processes (e.g., checking for variable frequency counts and patterns 
of skipping questions), were implemented to verify collection of correct data and ensure 
the survey produces stable and consistent results (CDC, 2013). 
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Recommendations 
Recommendations for Future Research 
The results of this current study provide a basis for multiple recommendations.  
Some recommendations for further research are grounded in the limitations of the current 
study, involving generalization, validity, and reliability.  To test this current study’s 
hypothesis, archival data during 2005 – 2006 was chosen from the NHANES data set.  
The entire data set was used to reflect the entire population and to answer the research 
question. To reduce the generalizability to the U.S. population as a whole, volunteers 
who participated in the NHANES were required to be at least 18 years, residing in the 
United States, were not institutionalized, and were mentally capable of responding to a 
questionnaire.  However, persons living in long-term care facilities, members of the 
federal military forces of the United States, those who are institutionalized, and U.S. 
nationals living in a foreign country, were not included in this current study.  A future 
study may consider including these populations as part of the larger group, or may 
examine these populations individually to gain insights into how they may be similar to 
or different from the participant who were eligible for inclusion under the NHANES 
parameters.   
Additional recommendations for further research emerge from an examination of 
the results of this study in relation to the literature reviewed in Chapter Two.  More 
research is needed to determine what role vitamin D supplementation may involve with 
preventing and treating depression (Penckofer, Kouba, Byrn, & Ferrans, 2010).  
Currently, public health initiatives are invested into raising awareness about the 
importance of physical exercise, consuming foods with adequate vitamin D or 
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supplementing a sufficient amount of vitamin D, to reduce the prevalence of VDD in the 
U.S.  If by improving vitamin D levels could enhance mental health, then taking part in 
physical activity in the sun and consuming nutrients rich in vitamin D to improve VDD 
could be measures that are simple and cost-effective to potentially reduce risks for 
depression (Penckofer et al., 2010).  Additional research is necessary to explore the 
potential of supplementation in addressing this issue.   
The inclusion of ethnicity as a moderating variable was beyond the scope of this 
study, yet ethnicity may influence VDD on depression in adults.  This current study had 
ample representation of Non-Hispanic White, Non-Hispanic Black, and Hispanic 
participants.  However, the non-Hispanic Asian American population lacked sufficient 
representation of participants in the current study. The 2005-2006 NHANES could have 
oversampled non-Hispanic Asian Americans to disseminate whether there is an influence 
of VDD on depression and is it moderated by demographic characteristics (gender, age, 
smoking status, or marital status) on this population subgroup. Further, data analysis 
involving non-Hispanic Asian Americans may add to the knowledge of ethnic 
differences. 
Recommendations for Practice 
 Most people in the United States do not recognize the severity of vitamin D 
status, largely because many who have VDD feel asymptomatic (Holick, 2008). Yet, 
scholar practitioners are aware that VDD can raise the risk for depression, type 1 
diabetes, type 2 diabetes, cardiovascular disease, stroke, auto-immune diseases (e.g., 
multiple sclerosis and rheumatoid arthritis; Thacher & Clarke, 2011).  People often 
believe that they will know when the onset of VDD occurs.  Signs and symptoms of 
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vitamin D deficiency frequently include pain in bones, joints, and muscles, which can 
lead to healthcare clinicians misdiagnosing as fibromyalgia, chronic fatigue syndrome, or 
depression (Holick, 2008).  The connection between vitamin D status and symptoms 
revealed are often not identified by general routine examination (Thacher & Clarke, 
2011).   
However, prompt medical treatment and assertive vitamin D replacement are 
advised at the onset of VDD (Thacher & Clarke, 2011).  Often medical practioners only 
provide a person who is vitamin D deficient with the required daily amount (i.e., 1000 
IU/day) of vitamin D3 (Holick, 2008).  This approach does not increase serum levels of 
25(OH)D sufficiently (Kjærgaard et a., 2012). Although no international standard has 
been established for vitamin D sufficiency, clinicians should consider rectifying VDD by 
understanding that the total dose of vitamin D is more predictive of vitamin D sufficiency 
rather than the frequency of dosing (Ish-Shalom et al., 2008). 
Pepper, Judd, Nanes, and Tangpricha (2009) performed a retrospective analysis to 
examine a suitable regimen that can be introduced to correct vitamin D insufficiency in 
healthy adults.  Approximately 300 healthy adults were prescribed varying levels of 
vitamin D2 to determine the most effective amount to achieve vitamin D sufficiency.  The 
investigators concluded that at least 600,000 IU of vitamin D2 appeared to be the most 
effective in achieving vitamin D sufficiency in nearly 65% of cases, avoiding vitamin D 
toxicity. Pepper et al. (2009), also indicate that guidelines for treatment of vitamin D 
insufficiency be developed for clinical practice to standardize the management of vitamin 
D insufficiency in healthy adults. 
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Implications for Positive Social Change 
This current study is a response to significant impacts that depression is having on 
the United States, which leads to economic strain, adversity, and dissatisfaction.  In 2012, 
United States health care spending exceeded $2.8 trillion, or $8,915 per person (Martin, 
Hartman, Whittle, & Catlin, 2014).  However, more than $25 billion was annually 
attributed to medical costs directed toward depression (Wade & Häring, 2010).  People 
with depression and those who are providing care to those with depression can be 
emotionally impacted, which can lead to immense suffering and interfere with QOL.  
These results reflect spending costs toward depression.  However, the spending 
amount attributed to depression could be higher than $2.8 trillion; many people who have 
a depressive disorder do not pursue treatment (National Institute of Mental Health, 2013).  
Further, the results do not reflect psychological and emotional costs that can be attributed 
to families, organizations, and societies.  There is a need for positive social change at all 
impacted levels (individual, family, organizational, and societal/policy). 
The material collected in this study contribute to improving human and social 
conditions by recommending efficient measures (e.g., screening and counseling) for 
patients with VDD to successfully respond to depression.  This study focused on 
exploring whether there is a relationship between vitamin D levels and depression, and 
how this might be moderated by an individual’s demographic characteristics such as 
gender, age, smoking status, or marital status. Understanding the connection between 
VDD and depression provides a basis on which to foster positive social change at the 
individual level, family, organizational, and societal level.  
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The results of the current study support positive social change aimed at 
broadening the understanding of a relationship between vitamin D levels and depression.  
This increased knowledge can positively enhance the general public’s understanding of 
predictors of depression in persons with VDD.  In addition, the results of this study can 
contribute to preventive strategies related to both depression and VDD when allocating 
resources and targeting education programs.  This study can also provide a basis for 
additional research focused on distinguishing groups at risk for VDD and depression, 
noting that the presence of one may be correlated with the presence of the second 
condition. 
The connection between vitamin D levels and depression status suggests that 
there is a need to recognize VDD as part of screening for development or triggering of 
depression risk factors (persistent feeling of sadness and loss of interest; emotional and 
physical distress). The current study shows that VDD and depression are related, thereby 
extending the existing literature that improvements in QOL, physical health and mental 
health are correlated to the relationship between VDD and depression.  Screening 
individuals with low levels of vitamin D may be a cost effective measure for determining 
potential depression. 
Conclusion 
The personal and public health consequences of depression and VDD are 
significant and evident. Depression is a significant and debilitating health illness that can 
impair an individual’s quality of life and cause regular activities to become challenging.  
Further, some people may be challenged with depression while concomitantly managing 
an additional chronic disease, which can impact the individual and their surroundings 
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(e.g., emotional burdens on family members and financial impact on society).  Failure to 
treat VDD or depression accordingly and effectively may cause further complications 
that may result in diminished quality of life to the individual and higher healthcare costs.  
Proper identification, analysis, and therapy may aid with early identification of at-risk 
patients. Also, efficient tools and evidence-based protocols that provide an aligned 
intervention that is patient centric can be valued as a holistic healthcare solution.  By 
proactively adopting practices and focusing on solutions that target the needs of persons 
with depression and low vitamin D levels, public health practitioners can enable positive 
outcomes and enhance patient quality of life in a measure that is cost-effective and 
simple. 
The results of this study provide a basis for constructive and effective social 
change in adults residing in the United States who are 18 years and older by 
implementing practices that acknowledge and address the connection between VDD and 
depression.  This study reports ample statistical evidence to suggest an important role for 
vitamin D in the incidence of depression.  However, demographic characteristics (gender, 
age, smoking status, and marital status) were reported not to have a significant role with 
the association between vitamin D levels and depression.  Consideration of demographic 
characteristics (gender, age, smoking status, and marital status) does not statistically 
satisfy the criteria of being significantly associated.  Therefore, until further 
investigations are conducted, determining demographic characteristics (gender, age, 
smoking status, and marital status) during screening should not be applied to populations 
who are at greater risk for VDD.  
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According to Penckofer et al. (2010), prompt detection and effective treatment 
when managing vitamin D levels in persons with depressive disorders may be a means to 
enhance an individual’s prospective health outcomes and their quality of life. From an 
evidence based research perspective, this current study provides empirical understandings 
for practice when investigating depression rates stemmed from low levels of vitamin D.  
Further, this current study may provide positive social change by strengthening public 
health policies and services.  
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Appendix A 
Tables 
Skewness and Kurtosis Statistics 
Table 18 
Skewness and Kurtosis Statistics of the Criterion and Predictor Variables by Gender 
 
Variable n Skewness Skew Std. Error z-skew Kurtosis 
Kurtosis 
Std. Error z-kurtosis 
Male        
   Depression 1140 1.72 0.07 23.86* 2.68 0.15 18.50* 
   Vitamin D 1140 0.41 0.07 5.74* 0.09 0.15 0.64 
        
Female        
   Depression 1483 1.52 0.06 23.78* 2.02 0.13 15.91* 
   Vitamin D 1483 0.43 0.06 6.64* -0.31 0.13 -2.46 
*Note.  Distribution was significantly skewed/kurtotic (z-skew/kurtosis > 3.29) 
 
Table 19 
Skewness and Kurtosis Statistics of the Criterion and Predictor Variables by Age Groups 
 
Variable n Skewness Skew Std. Error z-skew Kurtosis 
Kurtosis 
Std. Error z-kurtosis 
18-29 years old        
   Depression 439 1.63 0.12 13.89* 2.52 0.23 10.80* 
   Vitamin D 439 0.49 0.12 4.16* -0.11 0.23 -0.45 
        
30-39 years old        
   Depression 470 1.69 0.11 14.99* 2.80 0.23 12.44* 
   Vitamin D 470 0.39 0.11 3.43* -0.22 0.23 -0.96 
        
40-49 years old        
   Depression 501 1.44 0.11 13.25* 1.61 0.22 7.40* 
   Vitamin D 501 0.52 0.11 4.75* 0.07 0.22 0.34 
        
50-59 years old        
   Depression 428 1.54 0.12 13.03* 1.81 0.24 7.68* 
   Vitamin D 428 0.36 0.12 3.07 -0.39 0.24 -1.65 
        
60 years and older        
   Depression 785 1.62 0.09 18.66* 2.40 0.17 13.80* 
   Vitamin D 785 0.38 0.09 4.38* -0.14 0.17 -0.78 
*Note.  Distribution was significantly skewed/kurtotic (z-skew/kurtosis > 3.29) 
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Table 20 
 
Skewness and Kurtosis Statistics of the Criterion and Predictor Variables by Smoking 
Status 
 
Variable n Skewness Skew Std. Error z-skew Kurtosis 
Kurtosis 
Std. Error z-kurtosis 
Do not smoke        
   Depression 1300 1.45 0.07 21.25* 1.48 0.14 10.85* 
   Vitamin D 1300 0.39 0.07 5.79* -0.22 0.14 -1.63 
        
Smoke        
   Depression 1323 1.75 0.07 26.15* 3.29 0.13 24.53* 
   Vitamin D 1323 0.47 0.07 7.01* -0.04 0.13 -0.30 
*Note.  Distribution was significantly skewed/kurtotic (z-skew/kurtosis > 3.29) 
 
Table 21 
Skewness and Kurtosis Statistics of the Criterion and Predictor Variables by Marital 
Status 
 
Variable n Skewness Skew Std. Error z-skew Kurtosis 
Kurtosis 
Std. Error z-kurtosis 
Single        
   Depression 1406 1.61 0.07 24.78* 2.34 0.13 17.98* 
   Vitamin D 1406 0.33 0.07 5.09* -0.16 0.13 -1.20 
        
Married        
   Depression 1217 1.56 0.07 22.26* 2.04 0.14 14.57* 
   Vitamin D 1217 0.59 0.07 8.43* 0.04 0.14 0.26 
*Note.  Distribution was significantly skewed/kurtotic (z-skew/kurtosis > 3.29) 
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